[go: up one dir, main page]

CN100420471C - Traditional Chinese medicine oral preparation for nourishing kidney and lung and preparation method thereof - Google Patents

Traditional Chinese medicine oral preparation for nourishing kidney and lung and preparation method thereof Download PDF

Info

Publication number
CN100420471C
CN100420471C CNB2005100030544A CN200510003054A CN100420471C CN 100420471 C CN100420471 C CN 100420471C CN B2005100030544 A CNB2005100030544 A CN B2005100030544A CN 200510003054 A CN200510003054 A CN 200510003054A CN 100420471 C CN100420471 C CN 100420471C
Authority
CN
China
Prior art keywords
add
ethanol
preparation
ophiopogon japonicus
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB2005100030544A
Other languages
Chinese (zh)
Other versions
CN1695728A (en
Inventor
叶湘武
张梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guizhou Yibai Pharmaceutical Co Ltd
Original Assignee
Guizhou Yibai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guizhou Yibai Pharmaceutical Co Ltd filed Critical Guizhou Yibai Pharmaceutical Co Ltd
Priority to CNB2005100030544A priority Critical patent/CN100420471C/en
Publication of CN1695728A publication Critical patent/CN1695728A/en
Application granted granted Critical
Publication of CN100420471C publication Critical patent/CN100420471C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

本发明涉及一种滋肾养肺的中药口服制剂及其制备方法,它主要由麦冬、五味子、熟地黄、山茱萸、牡丹皮、山药等药材及辅料制备成胶囊剂、滴丸、片剂、颗粒剂、丸剂或口服液等;与现有技术相比,本发明采用的制备方法能使得到的药物更加精炼,药效更加显著,对于肺肾阴亏,潮热盗汗,咽干咳血,眩晕耳鸣,腰膝酸软等有较好的治疗作用。The present invention relates to an oral preparation of traditional Chinese medicine for nourishing kidney and lung and its preparation method. It is mainly prepared into capsules, dripping pills, tablets, Granules, pills or oral liquids, etc.; compared with the prior art, the preparation method adopted in the present invention can make the obtained medicine more refined, and the drug effect is more significant, and it is suitable for lung and kidney yin deficiency, hot flashes and night sweats, dry throat and hemoptysis, and dizziness Tinnitus, soreness of the waist and knees, etc. have a good therapeutic effect.

Description

滋肾养肺的中药口服制剂及其制备方法 Traditional Chinese medicine oral preparation for nourishing kidney and lung and preparation method thereof

技术领域: Technical field:

本发明涉及一种滋肾养肺的中药口服制剂及其制备方法,属于药品技术的领域。The invention relates to a traditional Chinese medicine oral preparation for nourishing the kidney and nourishing the lung and a preparation method thereof, belonging to the field of pharmaceutical technology.

技术背景:肺肾阴亏,眩晕耳鸣,腰膝酸软等疾病是威胁当今人民身体健康的常见疾病,给广大患者带来了极大的痛苦。市售麦味地黄片、麦味地黄丸和麦味地黄口服液具有滋肾养肺的作用,其处方是在六味地黄制剂的基础上增加麦冬与五味子共八味药组成,方中熟地黄滋补肾阴,填精益髓,山茱萸补益肝肾,滋养脾阴;山药补益肺肾滋养脾阴;牡丹皮清泄肾火;茯苓、泽泻清热利尿;诸药互相配合,共奏滋养肝肾与养肺生津之功。是治疗肺肾阴亏,潮热盗汗,咽干咳血,眩晕耳鸣,腰膝酸软和消渴疾病的较好药物之一。在生产麦味地黄制剂的方法中比较有代表性的是采用现有的部颁标准上记载的方法,其中,麦味地黄片是将麦冬、山药、茯苓、牡丹皮粉碎成细粉;五味子、熟地黄、山茱萸、泽泻用水煎煮,浓缩成稠膏,再与细粉混均,制粒后压片得到药品。麦味地黄口服液是将所有药材用水煎煮、浓缩、放置过夜,滤液再浓缩,冷藏,与蔗糖混合后制得药品;麦味地黄丸是将泽泻、麦冬、茯苓煎煮,浓缩成清膏;熟地黄单独煎煮,浓缩成清膏;五味子、处方量56%的牡丹皮和59%的山茱萸用70%乙醇渗漉提取,回收乙醇并浓缩成清膏;剩余山药、牡丹皮和山茱萸粉碎成细粉,再与上述各清膏混匀,制丸得到药品。而中国药典2005版记载的麦味地黄丸的制法是将所有药材粉碎成细粉,过筛,混匀后用炼蜜泛丸制得药品。经研究我们发现,由于以上工艺不够完善,所以用以上方法制得的麦味地黄制剂中含有大量的无效成分和杂质,使用时服用量大,给患者带来心理上的不安,且生物利用度不高;通过大量的实验,我们发现,在构成麦味地黄制剂的八味药物中,牡丹皮中含有丹皮酚、山茱萸中含有熊果酸、五味子中含有五味子乙素、麦冬中含有麦冬总皂苷,由于丹皮酚、熊果酸、五味子乙素、麦冬总皂苷均是本药物中具有重要功效的成份,另外由于丹皮酚为挥发性成份,若粉碎后直接入药则杂质含量多,加热水煮或用乙醇渗漉提取丹皮酚又容易挥发;而熊果酸、五味子乙素、麦冬总皂苷均难溶于水、易溶于醇,所以简单的水煮方法使得以上有效成分提取率低,若粉碎后直接入药又使得药物中含有大量的无效成份,而乙醇渗漉提取五味子和山茱萸的有效成分提取率又不够高,故用以上方法制备的麦味地黄制剂的临床疗效不够理想。Technical background: Yin deficiency of the lung and kidney, dizziness, tinnitus, soreness of the waist and knees and other diseases are common diseases that threaten the health of the people today, and bring great misery to the majority of patients. The commercially available Maiwei Dihuang Tablets, Maiwei Dihuang Pills and Maiwei Dihuang Oral Liquid have the effect of nourishing the kidneys and nourishing the lungs. The prescription is based on the Liuwei Dihuang preparation, which is composed of eight herbs including Ophiopogon japonicus and Schisandra chinensis. In the prescription, Shudihuang nourishes the kidneys Yin, filling essence and marrow, dogwood nourishing liver and kidney, nourishing spleen yin; The power of promoting body fluid. It is one of the better medicines for treating lung and kidney yin deficiency, hot flashes and night sweats, dry throat and coughing up blood, dizziness and tinnitus, soreness of waist and knees and thirst. In the method for producing Maiwei Dihuang preparations, the method recorded in the existing ministerial standards is more representative, wherein Maiwei Dihuang tablets are made by pulverizing Ophiopogon japonicus, Chinese yam, Poria cocos and Cortex Moutan into fine powder; Schisandra chinensis, Rehmannia glutinosa, Cornus officinalis and Alisma alisma are decocted with water, concentrated into a thick paste, then mixed with fine powder, granulated and pressed into tablets to obtain medicines. Maiwei Dihuang Oral Liquid is prepared by decocting all the medicinal materials with water, concentrating them, leaving them overnight, concentrating the filtrate, refrigerating, and mixing them with sucrose; Qingpao; Rehmannia glutinosa is decocted separately and concentrated into Qingpao; Schisandra chinensis, 56% of Moutan bark and 59% of Cornus officinalis are extracted by percolation with 70% ethanol, and the ethanol is recovered and concentrated into Qingpao; the remaining yam, Moutan bark and Cornus officinalis is crushed into fine powder, then mixed with the above-mentioned clear pastes, and made into pills to obtain medicines. And the preparation method of Maiwei Dihuang Pills recorded in Chinese Pharmacopoeia 2005 edition is to pulverize all the medicinal materials into fine powder, sieve, mix and make medicines with Lianmi Panwan Pills. After research, we found that due to the imperfection of the above process, the Maiwei Dihuang preparation prepared by the above method contains a large number of invalid ingredients and impurities, and the dosage is large when used, which brings psychological anxiety to the patient. Not high; through a large number of experiments, we found that among the eight herbs that constitute the preparation of Maiwei Dihuang, Moutan Cortex contains paeonol, Cornus officinalis contains ursolic acid, Schisandra chinensis contains Schizandrin B, and Ophiopogon japonicus contains wheat Total winter saponins, because paeonol, ursolic acid, schisandrin, and total saponins of Ophiopogon japonicus are all ingredients with important effects in this medicine. In addition, because paeonol is a volatile component, if it is directly used after crushing, the impurity content will be reduced. It is easy to volatilize paeonol by boiling in water or percolating with ethanol; while ursolic acid, schisandrin, and total saponins of Ophiopogon japonicus are insoluble in water and easily soluble in alcohol, so the simple boiling method makes the above The extraction rate of active ingredients is low, and if it is directly used as medicine after crushing, the medicine will contain a large amount of ineffective ingredients, and the extraction rate of active ingredients from Schisandra chinensis and Cornus officinalis by ethanol percolation is not high enough, so the clinical application of Maiwei Dihuang preparation prepared by the above method Curative effect is not ideal enough.

发明内容: Invention content:

本发明的目的在于:提供一种滋肾养肺的中药口服制剂及其制备方法,这种制剂是指临床上所有口服制剂,包括:胶囊剂、滴丸、片剂、颗粒剂、丸剂、口服液等;本发明的另一个目的在于公开制备这些滋肾养肺的中药制剂的制备方法。在本发明中,针对牡丹皮中的丹皮酚具有挥发性的特点,本发明采用水蒸气蒸馏法提取丹皮酚,针对山茱萸中的熊果酸、五味子中的五味子乙素和麦冬中的麦冬总皂苷难溶于水、易溶于醇的特点,本发明采用乙醇提取的方法提取熊果酸、五味子乙素和麦冬总皂苷。由于用本发明方法制备的麦味地黄制剂具有有效成份含量较高的特点,所以能够达到提高生物利用率的效果。本发明是这样构成的:按照重量组份计算:它主要由麦冬30-120、制五味子20-80、熟地黄80-320、制山茱萸40-160、牡丹皮30-120、山药40-160、茯苓30-120和泽泻30-120及辅料制备而成。具体的说:按照重量组份计算:它主要由麦冬60、制五味子40、熟地黄160、制山茱萸80、牡丹皮60、山药80、茯苓60和泽泻60及辅料制备成临床上所有口服制剂。包括:胶囊剂、滴丸、片剂、颗粒剂、丸剂或口服液。The object of the present invention is to provide a kind of traditional Chinese medicine oral preparation for nourishing the kidney and nourishing the lung and its preparation method. This preparation refers to all clinical oral preparations, including: capsules, dripping pills, tablets, granules, pills, oral Liquid, etc.; Another object of the present invention is to disclose the preparation method of these traditional Chinese medicine preparations for nourishing the kidney and nourishing the lung. In the present invention, aiming at the volatile characteristics of paeonol in Moutan cortex, the present invention extracts paeonol by steam distillation, and aims at ursolic acid in Cornus officinalis, Schizandrin B in Schisandra chinensis and Radix Ophiopogon japonicus. The total saponins of Ophiopogon japonicus are difficult to dissolve in water and easily soluble in alcohol. The present invention adopts the method of ethanol extraction to extract ursolic acid, schisandra B and total saponins of Ophiopogon japonicus. Because the Maiwei Dihuang preparation prepared by the method of the invention has the characteristics of high content of active ingredients, it can achieve the effect of improving bioavailability. The present invention is constituted as follows: calculated according to weight components: it is mainly composed of 30-120 Ophiopogon japonicus, 20-80 schisandra chinensis, 80-320 rehmannia glutinosa, 40-160 dogwood 40-160, 30-120 moutan cortex, 40-160 yam , Poria 30-120, Alisma 30-120 and auxiliary materials. Specifically: Calculated according to weight components: it is mainly prepared from 60 Ophiopogon japonicus, 40 schisandra chinensis, 160 rehmannia glutinosa, 80 dogwood, 60 Moutan cortex, 80 yam, 60 Poria cocos, 60 Alisma 60 and auxiliary materials. preparation. Including: capsules, dripping pills, tablets, granules, pills or oral liquid.

本发明所述制剂的制备工艺为:茯苓部分或全部粉碎成100目以上的细粉,牡丹皮用水蒸汽蒸馏提取丹皮酚;麦冬、五味子、山茱萸用乙醇提取、滤过、滤液浓缩至稠膏状;将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻加水煎煮,提取液滤过,合并滤液,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏,茯苓粉和丹皮酚混合均匀,再加入不同的辅料按照常规的方法可以制成不同的制剂。The preparation process of the preparation of the present invention is as follows: part or all of Poria cocos is crushed into fine powder of more than 100 meshes, paeonol is extracted from Moutan cortex with steam distillation; Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis are extracted with ethanol, filtered, and the filtrate is concentrated to thick Paste; decoct the distilled aqueous solution of Moutan cortex and dregs, ethanol-extracted dregs of Ophiopogon japonicus, Schisandra, and Cornus officinalis, and the remaining Poria cocos, yam, Rehmannia glutinosa, and Alisma, filter the extract, and combine the filtrates. Concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste, Poria powder and paeonol, mix evenly, and then add different auxiliary materials to make different preparations according to conventional methods.

具体的制备方法为:茯苓部分或全部粉碎成100目以上的细粉,牡丹皮用水蒸汽蒸馏提取丹皮酚;麦冬、五味子、山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩成浸膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,浓缩成浸膏,再加入上述麦冬、五味子、山茱萸浸膏,茯苓粉和丹皮酚混合均匀,再加入不同的辅料按照常规的方法可以制成不同的制剂。The specific preparation method is as follows: part or all of Poria cocos is crushed into a fine powder of more than 100 meshes, paeonol is extracted from Moutan cortex by steam distillation; Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis are extracted 1-5 times with ethanol reflux, each time for 0.5-5 hours , filter, combine the filtrates and concentrate into extracts, add the distilled aqueous solution of Moutan cortex and medicinal residues, the medicinal residues after ethanol extraction of Ophiopogon japonicus, Schisandra, and Cornus officinalis, and the remaining Poria cocos, yam, Rehmannia glutinosa, and Alisma, add 3- Decoct with 10 times the amount of water for 1-5 times, each time for 1-5 hours, filter the extract, combine the filtrate, concentrate it into an extract, then add the above-mentioned Radix Ophiopogon japonicus, Schisandra, Cornus officinalis extract, Poria powder and paeonol Mix evenly, and then add different auxiliary materials to make different preparations according to conventional methods.

但是在实验中我们发现,本发明制剂还未达到最佳的精制效果,如果在本制剂中利用大孔吸附树脂法提取药材中的有效成份,本药物将更加精炼,药效更加显著。所以本发明制剂的制备方法还可以为:茯苓部分或全部粉碎成100目以上的细粉;牡丹皮用水蒸汽蒸馏提取丹皮酚;麦冬、五味子、山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩成浸膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50-80%的乙醇进行洗脱,回收乙醇,浓缩成浸膏,再加入上述麦冬、五味子、山茱萸浸膏,茯苓粉和丹皮酚混合均匀,再加入不同的辅料按照常规的方法可以制成不同的制剂。But in the experiment, we found that the preparation of the present invention has not yet reached the best refining effect. If the macroporous adsorption resin method is used to extract the active ingredients in the medicinal material in this preparation, the medicine will be more refined and the drug effect will be more significant. So the preparation method of the preparation of the present invention can also be: Poria cocos part or all is ground into the fine powder of more than 100 orders; Cortex Moutan steam distillation extracts paeonol; After 0.5-5 hours, filter, combine the filtrates and concentrate into an extract, distill the aqueous solution of Moutan cortex and herbal residues, extract the medicinal residues of Ophiopogon japonicus, Schisandra, and Cornus officinalis, and the remaining Poria cocos, yam, Rehmannia glutinosa, Add 3-10 times the amount of water to decoct Alisma 1-5 times, 1-5 hours each time, filter the extract, combine the filtrate, pass through a macroporous adsorption resin column, and elute with 50-80% ethanol, The ethanol is recovered, concentrated into an extract, and then the extracts of Ophiopogon japonicus, Schisandra, Cornus officinalis, Poria powder and paeonol are added and mixed evenly, and then different auxiliary materials are added to make different preparations according to conventional methods.

在实验过程中我们又发现,用以上方法制备的麦味地黄制剂中所含的丹皮酚还存在着易挥发的缺点,如果用环糊精将丹皮酚包合,就可防止丹皮酚挥发,确保本药物的疗效。所以本发明制剂的制备方法还可以为:茯苓部分或全部粉碎成100目以上的细粉;牡丹皮用水蒸汽蒸馏,蒸馏液用0.5-5倍量的环糊精进行包合,包合物低温干燥,粉碎成细粉即得;麦冬、五味子、山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩成浸膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50-80%的乙醇进行洗脱,回收乙醇,浓缩成浸膏,再加入上述麦冬、五味子、山茱萸浸膏,茯苓粉和丹皮酚环糊精包合物混合均匀,再加入不同的辅料按照常规的方法可以制成不同的制剂。During the experiment, we also found that the paeonol contained in the Maiwei Dihuang preparation prepared by the above method still has the disadvantage of being volatile. If paeonol is included with cyclodextrin, it can prevent paeonol from being released. Volatilize to ensure the curative effect of this medicine. Therefore, the preparation method of the preparation of the present invention can also be as follows: Poria cocos is partially or completely crushed into fine powder of more than 100 mesh; Moutan cortex is steam distilled, and the distillate is clathrated with 0.5-5 times the amount of cyclodextrin, and the clathrate is low-temperature Dried and crushed into fine powder; Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis were extracted 1-5 times with ethanol reflux, each time for 0.5-5 hours, filtered, combined filtrates and concentrated into extract, distilled aqueous solution of Moutan bark and Add 3-10 times the amount of water to decoct the dregs of Ophiopogon japonicus, Schisandra chinensis, Cornus officinalis after ethanol extraction and the remaining Poria cocos, yam, rehmannia glutinosa, and Alisma 1-5 times, each time for 1-5 hours, extract Filtrate the liquid, combine the filtrates, pass through the macroporous adsorption resin column, elute with 50-80% ethanol, recover the ethanol, concentrate it into an extract, then add the extracts of Radix Ophiopogon japonicus, Schisandra, Cornus officinalis, Poria cocos powder and paeonol The inclusion compound of phenol cyclodextrin is mixed evenly, and then different auxiliary materials are added according to conventional methods to prepare different preparations.

比较具体的说:本发明所述胶囊剂的制备工艺为:茯苓部分或全部粉碎成100目以上的细粉;牡丹皮用水蒸汽蒸馏提取丹皮酚;麦冬、五味子、山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50-80%的乙醇进行洗脱,回收乙醇,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏,茯苓粉混合制粒,微波干燥,粉碎,再与丹皮酚混合均匀,制粒,装入胶囊即得。More specifically: the preparation process of the capsules of the present invention is as follows: Poria cocos is partly or completely pulverized into fine powder above 100 mesh; Cortex Moutan is steam-distilled to extract paeonol; -5 times, each time for 0.5-5 hours, filter, combine the filtrate and concentrate to a thick paste, distill the water solution and dregs of Moutan cortex, extract dregs of Radix Ophiopogon japonicus, Schisandra, Cornus officinalis and the remaining Poria cocos , yam, Rehmannia glutinosa, and Alisma, add 3-10 times the amount of water and decoct 1-5 times, 1-5 hours each time, filter the extract, combine the filtrate, pass through a macroporous adsorption resin column, and use 50-80% The ethanol was eluted, the ethanol was recovered, concentrated to a thick paste, and then the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste, and Poria powder were mixed and granulated, microwave dried, pulverized, then mixed with paeonol evenly, granulated, and packed Serve in capsules.

本发明所述滴丸的制备工艺为:茯苓部分或全部粉碎成80-100目的细粉;再将其放置在超微粉碎设备中继续粉碎至200-300目的微粉;牡丹皮用水蒸汽蒸馏,蒸馏液用0.5-5倍量的环糊精进行包合,包合物低温干燥,粉碎成细粉即得;麦冬、五味子、山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩成清膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50-80%的乙醇进行洗脱,回收乙醇,浓缩成清膏,再加入上述麦冬、五味子、山茱萸清膏和茯苓微粉混合制粒,干燥,再与丹皮酚环糊精包合物混合均匀:将所得的药粉或颗粒加入已经加热熔融的聚乙二醇4000、聚乙二醇6000、硬脂酸钠或甘油明胶基质中,保持恒定温度78-102℃,用滴管滴入甲基硅油中,收集滴丸即得。The preparation process of the dripping pills of the present invention is as follows: Poria cocos is partially or completely pulverized into 80-100 mesh fine powder; then it is placed in an ultra-fine pulverizing device to continue pulverizing into 200-300 mesh fine powder; The solution is clathrated with 0.5-5 times the amount of cyclodextrin, the clathrate is dried at low temperature, and crushed into a fine powder; Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis are extracted 1-5 times with ethanol reflux, each time for 0.5-5 hours, Filtrate, combine the filtrates and condense into a clear paste, add the distilled aqueous solution of Moutan cortex and medicinal residues, the medicinal residues extracted by ethanol from Ophiopogon japonicus, Schisandra, and Cornus officinalis, and the remaining Poria cocos, yam, Rehmannia glutinosa, and Alisma, for 3-10 minutes. Doubling the amount of water and decocting 1-5 times, 1-5 hours each time, filtering the extract, combining the filtrate, passing through a macroporous adsorption resin column, eluting with 50-80% ethanol, recovering the ethanol, and concentrating into clear Then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis ointment and Poria cocos powder, mix and granulate, dry, and mix evenly with paeonol cyclodextrin inclusion compound: Add the obtained medicine powder or granules to polyethylene glycol that has been heated and melted Alcohol 4000, polyethylene glycol 6000, sodium stearate or glycerin gelatin matrix, keep a constant temperature of 78-102 ° C, drop into methyl silicone oil with a dropper, and collect drop pills.

本发明所述丸剂的制备工艺为:茯苓部分或全部粉碎成100目以上的细粉;牡丹皮用水蒸汽蒸馏提取丹皮酚;麦冬、五味子、山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50-80%的乙醇进行洗脱,回收乙醇,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏和茯苓粉混合,进行喷雾干燥,粉碎,过60目及60目以上的筛网,加入丹皮酚混合均匀,再加入药粉量0.3-1倍量的炼蜜合药,制成蜜丸即可。The preparation process of the pills of the present invention is as follows: part or all of Poria cocos is crushed into a fine powder of more than 100 meshes; paeonol is extracted from Moutan cortex by water steam distillation; 0.5-5 hours, filter, combine the filtrate and concentrate to a thick paste, distill the aqueous solution of Moutan cortex and herbal residues, extract the medicinal residues of Ophiopogon japonicus, Schisandra, and Cornus officinalis, and the remaining Poria cocos, yam, Rehmannia glutinosa, Add 3-10 times the amount of water to decoct Alisma 1-5 times, 1-5 hours each time, filter the extract, combine the filtrate, pass through a macroporous adsorption resin column, and elute with 50-80% ethanol, Recover ethanol, concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste and Poria cocos powder to mix, spray dry, pulverize, pass through a sieve of 60 mesh or above, add paeonol and mix evenly, then Add 0.3-1 times the amount of powdered honey and medicine to make honeyed pills.

本发明所述片剂的制备工艺为:茯苓部分或全部粉碎成100目以上的细粉;牡丹皮用水蒸汽蒸馏,蒸馏液用0.5-5倍量的环糊精进行包合,包合物低温干燥,粉碎成细粉即得;麦冬、五味子、山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50-80%的乙醇进行洗脱,回收乙醇,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏和茯苓粉混合,进行喷雾干燥,加入处方量5-20%淀粉和上述丹皮酚环糊精包合物混匀,用乙醇制粒,再加入干颗粒量0.5-1%硬脂酸镁混匀,压片,用2-8%薄膜包衣剂对素片进行包衣,即得片剂。The preparation process of the tablet of the present invention is as follows: part or all of Poria cocos is crushed into a fine powder of more than 100 meshes; Moutan cortex is distilled with water steam, and the distillate is clathrated with 0.5-5 times the amount of cyclodextrin, and the clathrate is low-temperature Dried and crushed into fine powder; Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis were extracted with ethanol reflux 1-5 times, each time for 0.5-5 hours, filtered, combined filtrates and concentrated to a thick paste, distilled Moutan cortex aqueous solution and medicinal dregs, the medicinal dregs after ethanol extraction of Ophiopogon japonicus, Schisandra, and Cornus officinalis, and the remaining Poria cocos, yam, Rehmannia glutinosa, and Alisma, add 3-10 times the amount of water to decoct 1-5 times, each time for 1-5 hours, Filtrate the extract, combine the filtrates, pass through a macroporous adsorption resin column, elute with 50-80% ethanol, recover the ethanol, concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste and Poria powder to mix , carry out spray drying, add 5-20% of the prescription amount of starch and the above paeonol-cyclodextrin inclusion compound and mix, granulate with ethanol, then add 0.5-1% of dry granule amount of magnesium stearate, mix evenly, and press into tablets , Coat the plain tablet with 2-8% film coating agent to obtain the tablet.

本发明所述颗粒剂的制备工艺为:牡丹皮用水蒸汽蒸馏提取丹皮酚;麦冬、五味子、山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与茯苓、山药、熟地黄、泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏,丹皮酚和2-5倍量的辅料混匀,制粒,即得颗粒剂。本发明颗粒剂所使用的辅料包括糊精、蔗糖、甜味剂、乳糖。The preparation process of the granules of the present invention is as follows: paeonol is extracted by water steam distillation from Moutan cortex; Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis are extracted 1-5 times with ethanol reflux, each time for 0.5-5 hours, filtered, combined filtrates and concentrated To a thick paste, add 3-10 times the amount of water to decoct the distilled aqueous solution of Moutan cortex and dregs, ethanol-extracted dregs of Ophiopogon japonicus, Schisandra, and Cornus officinalis, Poria cocos, yam, Rehmannia glutinosa, and Alisma. 5 times, each time for 1-5 hours, filter the extract, combine the filtrates, concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste, paeonol and 2-5 times the amount of auxiliary materials and mix well, Granulation, that is, granules. The auxiliary materials used in the granules of the present invention include dextrin, sucrose, sweeteners, and lactose.

本发明所述口服液体制剂的制备工艺为:牡丹皮用水蒸汽蒸馏,收集蒸馏液即得;剩下的药物加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,滤过,滤液浓缩,静置10-50小时,取上清液,滤过,滤液继续浓缩,冷藏10-50小时,滤过滤液加入蔗糖使最终含糖量5-60%,煮沸溶解,滤过,加入0.06%-0.8%苯甲酸钠,加水至全量,搅匀,即得。The preparation process of the oral liquid preparation of the present invention is as follows: steam distillation of Cortex Moutan, collect the distillate to get final product; add 3-10 times the amount of water to decoct the remaining medicine for 1-5 times, each time for 1-5 hours, Filter the extract, combine the filtrate, filter, concentrate the filtrate, let it stand for 10-50 hours, take the supernatant, filter, continue to concentrate the filtrate, refrigerate for 10-50 hours, add sucrose to the filtrate to make the final sugar content 5 -60%, boil to dissolve, filter, add 0.06%-0.8% sodium benzoate, add water to the full amount, stir well, and get ready.

本发明中牡丹皮直接提取丹皮酚的方法为:药材加5-10倍量水,改良油水分离器中加1.0-2.5%的醋酸乙酯,蒸馏提取8-14h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,低温干燥,研成细粉即得。所说的挥发油环糊精包合的方法为饱和水溶液法;包合温度为30-40℃,超声时间为25-35min。本发明中所述环糊精包括α-环糊精、β-环糊精、γ-环糊精,最佳为β-环糊精。The method for directly extracting paeonol from Cortex Moutan in the present invention is: adding 5-10 times the amount of water to the medicinal material, adding 1.0-2.5% ethyl acetate to the improved oil-water separator, distilling and extracting for 8-14h, and extracting the distillate After volatile oil, recover ethyl acetate under reduced pressure, dry at low temperature, and grind into fine powder. The method for the inclusion of volatile oil cyclodextrin is a saturated aqueous solution method; the inclusion temperature is 30-40° C., and the ultrasonic time is 25-35 minutes. Said cyclodextrin in the present invention includes α-cyclodextrin, β-cyclodextrin, γ-cyclodextrin, and the best is β-cyclodextrin.

与现有技术相比,本发明采用水蒸气蒸馏法提取牡丹皮中的丹皮酚,避免了常规水煎煮提取或乙醇渗漉提取造成挥发油的损失,或直接粉碎入药造成的杂质含量过高;用环糊精包合挥发油,能防止丹皮酚挥发;另外针对山茱萸中的熊果酸、五味子中的五味子乙素和麦冬中的麦冬总皂苷难溶于水、易溶于醇的特点,采用乙醇提取的方法提取熊果酸、五味子乙素和麦冬总皂苷,避免了常规水煎煮提取或乙醇渗漉提取时,以上有效成分提取率低或直接粉碎入药无效成份含量高的缺点;采用大孔吸附树脂法提取药材中的有效成份,使得本药物更加精炼,药效更加显著,对于肺肾阴亏,潮热盗汗,咽干咳血,眩晕耳鸣,腰膝酸软等有较好的治疗作用。用本发明方法制备的制剂与现有制剂比较,服用量减小,生物利用度高;另外本发明方法制备的滴丸和胶囊具有比表面积大,溶出速度快的特点,还掩盖了现有制剂口服液、浓缩丸的苦、涩、酸等不良味道,更能方便患者服用。本发明方法制备的颗粒剂具有细度小,颗粒均匀,易于溶解和吸收的特点,并且口感好,无焦味,克服了原制剂带来药品的酸味,同时,革除了部分不溶性成份在口腔中滞留的副作用。本发明片剂、丸剂和口服液体制剂克服原制剂服用量大,吸收不好的缺点。且片剂成型性、崩解性好,能大幅度降低颗粒的吸湿性,增加药品稳定性。另外,剂型多样化,便于医疗需要,达到了发明的目的。Compared with the prior art, the present invention adopts steam distillation to extract paeonol in Moutan Cortex, which avoids the loss of volatile oil caused by conventional water decoction extraction or ethanol percolation extraction, or the high impurity content caused by direct crushing into medicine ; Encapsulate volatile oil with cyclodextrin, which can prevent paeonol from volatilizing; in addition, for ursolic acid in dogwood, schisandrin in Schisandra chinensis and total saponins of Radix Ophiopogon japonicus in Ophiopogon japonicus, which are insoluble in water and easily soluble in alcohol Features, using ethanol extraction method to extract ursolic acid, schisandra B and total saponins of Ophiopogon japonicus, avoiding the low extraction rate of the above active ingredients or the high content of ineffective ingredients directly crushed into medicine during conventional water decoction extraction or ethanol percolation extraction Disadvantages: The active ingredients in the medicinal materials are extracted by the macroporous adsorption resin method, which makes the drug more refined and more effective. It is better for lung and kidney yin deficiency, hot flashes and night sweats, dry throat and coughing up blood, dizziness, tinnitus, soreness of the waist and knees, etc. therapeutic effect. Compared with the existing preparations, the preparation prepared by the method of the present invention has reduced dosage and high bioavailability; in addition, the dropping pills and capsules prepared by the method of the present invention have the characteristics of large specific surface area and fast dissolution rate, which also cover the oral cavity of the existing preparations. Bitter, astringent, sour and other bad tastes of liquid and concentrated pills are more convenient for patients to take. The granule prepared by the method of the invention has the characteristics of small fineness, uniform granule, easy dissolution and absorption, good taste, no burnt taste, overcomes the sour taste of the medicine brought by the original preparation, and at the same time, removes some insoluble components in the oral cavity lingering side effects. The tablets, pills and oral liquid preparations of the present invention overcome the disadvantages of large dosage and poor absorption of the original preparations. Moreover, the formability and disintegration of the tablet are good, which can greatly reduce the hygroscopicity of the granules and increase the stability of the drug. In addition, the dosage form is diversified, which is convenient for medical needs and achieves the purpose of the invention.

本发明实验1:五味子和山茱萸提取工艺实验研究Experiment 1 of the present invention: experimental research on the extraction process of Schisandra chinensis and Cornus officinalis

分别称取五味子、山茱萸各50g,用10倍量80%的乙醇回流提取2次,每次2小时,提取液回收乙醇,即得;另取五味子、山茱萸各50g,用70%的乙醇浸泡24小时后渗漉提取,提取液回收乙醇,即得;分别检测其中熊果酸和五味子乙素的含量,计算提取率,结果为:Weigh 50g each of Schisandra chinensis and Cornus officinalis, and reflux extract twice with 10 times the amount of 80% ethanol for 2 hours each time, and recover the ethanol from the extract; take another 50g each of Schisandra chinensis and Cornus officinalis, soak in 70% ethanol for 24 Percolation and extraction after 1 hour, the ethanol was reclaimed from the extract, and it was obtained; the contents of ursolic acid and schisandrin B were detected respectively, and the extraction rate was calculated, and the results were:

  项目 project   熊果酸 Ursolic acid   无味子乙素 Ordinin B   乙醇回流提取 Ethanol reflux extraction   2.3% 2.3%   56.2% 56.2%   乙醇渗漉提取 Ethanol percolation extraction   1.51% 1.51%   49.7% 49.7%

根据以上实验结果表明,乙醇回流提取优于乙醇渗漉提取。According to the above experimental results, the ethanol reflux extraction is better than the ethanol percolation extraction.

本发明实验2:本发明制剂对阴虚证模型动物的影响Experiment 2 of the present invention: the influence of the preparation of the present invention on Yin deficiency syndrome model animals

一、材料1. Materials

1、药物:本发明制备的片剂、本发明制备的丸剂、本发明制备的胶囊剂,均按照本发明方法制备;麦味地黄片、麦味地黄丸,均市售;三碘甲状腺原氨酸(T3)。1. Medicine: the tablets prepared by the present invention, the pills prepared by the present invention, and the capsules prepared by the present invention are all prepared according to the method of the present invention; Maiwei Dihuang Tablets and Maiwei Dihuang Pills are all commercially available; triiodothyronine (T 3 ).

2、动物昆明种小鼠和SD系大鼠。2. Animals Kunming mice and SD rats.

二、方法与结果2. Methods and results

1、对阴虚小鼠血浆CAMP及肝糖原的影响:试验采用T3法建立阴虚证动物模型。雄性小鼠50只,体重18~22g,随机分5组,每日灌服蒸馏水或药物1次连续10天,于给药第6天开始,灌服T318ul/只连续5天造型。实验结束处死动物,用蛋白结合法测定血浆CAMP,用蒽酮法测肝糖原,结果见下表。1. Effects on plasma CAMP and liver glycogen in mice with yin deficiency: The T 3 method was used to establish an animal model of yin deficiency. Fifty male mice, weighing 18-22g, were randomly divided into 5 groups, fed with distilled water or drugs once a day for 10 consecutive days, starting from the 6th day of administration, and fed with T3 18ul/mouse for 5 consecutive days. At the end of the experiment, the animals were sacrificed, the plasma CAMP was measured by the protein binding method, and the liver glycogen was measured by the anthrone method. The results are shown in the table below.

本发明片剂对阴虚小鼠血浆CAMP、肝糖原的影响(x±SD)Tablet of the present invention is to the influence (x ± SD) of blood plasma CAMP, liver glycogen of yin-deficiency mice

  组别 group   剂量(g/kg) Dose (g/kg)   动物数(只) Number of animals (only)   血浆CAMP(pM/ml) Plasma CAMP (pM/ml)   肝糖原(g/100g肝) Liver glycogen (g/100g liver)   对照组 control group   - -   10 10   92.74±27.05 92.74±27.05   1.27±0.41 1.27±0.41   造型组 Styling group   - -   10 10   127.88±29.75^ 127.88±29.75^   0.85±0.37^ 0.85±0.37^   本发明片剂 Tablet of the present invention   1.5 1.5   10 10   91.45±21.15 91.45±21.15   1.30±0.40 1.30±0.40   麦味地黄片 Wheat Rehmannia Slices   3 3   10 10   91.21±12.78 91.21±12.78   1.31±0.47 1.31±0.47

由上表可以看出,本发明片剂1.5g/kg剂量组与市售麦味地黄片3g/kg剂量组比较无显著性差异P>0.05。It can be seen from the above table that there is no significant difference P>0.05 between the 1.5g/kg dose group of the tablet of the present invention and the 3g/kg dose group of the commercially available Maiwei Dihuang tablet.

2、对阴虚大鼠体重、过氧化脂质、肾上腺皮质功能及血象的影响:大白鼠雌雄兼用,体重226.4±3.4g,随机均分为5组,每日灌药或同体积蒸馏水1次,连续10天。于给药第7天起灌服T3500ul/kg每日1次,连续3天。实验结束处死动物,取肝、肾上腺及血样标本,分别用硫代巴比妥酸比色法检测肝MDA,用2、4-二硝基苯肼显色法测定肾上腺维生素C的含量,并观测血象的改变,结果见下表2. Effects on body weight, lipid peroxide, adrenal cortex function and blood picture of rats with yin deficiency: male and female rats, body weight 226.4±3.4g, were randomly divided into 5 groups, fed medicine or distilled water of the same volume once a day , for 10 consecutive days. From the 7th day of administration, T 3 500ul/kg was administered once a day for 3 consecutive days. At the end of the experiment, the animals were sacrificed, and the liver, adrenal gland and blood samples were taken, and the MDA in the liver was detected by the thiobarbituric acid colorimetric method, and the vitamin C content in the adrenal gland was determined by the 2,4-dinitrophenylhydrazine colorimetric method, and observed. Changes in hemogram, the results are shown in the table below

本发明丸剂对阴虚大鼠体重、MDA及VitC的影响(x±SD)Effect (x ± SD) of pill of the present invention on body weight, MDA and VitC of yin deficiency rats

  组别 group   剂量(g/kg) Dose (g/kg)   体重增减(g)(给药前后) Weight gain or loss (g) (before and after administration)   MDA(10<sup>-7</sup>mol/g肝) MDA (10<sup>-7</sup>mol/g liver)   VitC(mg/100g肾上腺) VitC (mg/100g adrenal gland)   对照组 control group   - -   8.0±12.3 8.0±12.3   1.9±0.1 1.9±0.1   295.1±21.3 295.1±21.3   造型组 Styling group   - -   -13.5±4.1^^ -13.5±4.1^^   2.5±0.4^^ 2.5±0.4^^   229.4±83.4^ 229.4±83.4^   本发明丸剂 Pills of the present invention   1 1   -7.9±7.5 -7.9±7.5   2.0±0.3 2.0±0.3   295.8±47.9 295.8±47.9   麦味地黄丸 Mai Wei Di Huang Wan   2 2   -8.0±3.2 -8.0±3.2   2.1±0.6 2.1±0.6   296.0±41.3 296.0±41.3

由上表可以看出,本发明丸剂1g/kg剂量组与市售麦味地黄丸2g/kg剂量组比较无显著性差异P>0.05。It can be seen from the above table that there is no significant difference between the 1 g/kg dosage group of the pills of the present invention and the 2 g/kg dosage group of the commercially available Maiwei Dihuang Pills, P>0.05.

本发明胶囊剂对阴虚大鼠血象的影响(x±SD)The influence (x ± SD) of capsule of the present invention on the hemogram of yin-deficiency rats

Figure C20051000305400161
Figure C20051000305400161

由上表可以看出,本发明丸剂1g/kg剂量组与市售麦味地黄丸2g/kg剂量组比较无显著性差异P>0.05。It can be seen from the above table that there is no significant difference between the 1 g/kg dosage group of the pills of the present invention and the 2 g/kg dosage group of the commercially available Maiwei Dihuang Pills, P>0.05.

上述结果表明,本发明丸剂1g/kg剂量组与市售麦味地黄丸2g/kg剂量组疗效相当。The above results show that the curative effect of the 1g/kg dosage group of the pills of the present invention is equivalent to that of the 2g/kg dosage group of the commercially available Maiwei Dihuang Pills.

3、对阴虚小鼠免疫功能的影响3. Effects on the immune function of mice with yin deficiency

3.1溶血空斑试验:取体重17~22g小鼠雌雄兼用,分组给药和用T3法建立阴虚证动物模型均同2.1。在给药第6天时,以新鲜绵羊红细胞悬液(SR-BC)免疫,每鼠4×108RBC/0.5ml ip。在免疫后第4天处死动物,分离血清和制备脾细胞悬液,用琼脂糖玻片法计数每张玻片上的空斑数目,计算小室容积。根据小室容积和混合液中脾细胞浓度校正每百万(1×106)脾细胞中含空斑形成细胞数(即PFC数/106脾细胞),结果见下表;血样标本按文献法检测血清凝集素,结果以log2滴度表示,结果也见下表;另有实验取小鼠60只,体重17~22g,同法分组灌药,用T3法造型以及用新鲜SRBC免疫,实验结束处死动物,采取血液标本,参照文献方法作E花结形成实验,观测E花结形成率,即红细胞玫瑰花形成细胞(ERFC)形成率,结果见下表。3.1 Hemolytic plaque test: Take mice weighing 17-22 g, both male and female, administer the drugs in groups and use the T3 method to establish an animal model of yin deficiency syndrome, all the same as in 2.1. On the 6th day of administration, immunize with fresh sheep red blood cell suspension (SR-BC), 4×10 8 RBC/0.5ml ip per mouse. Animals were sacrificed on the 4th day after immunization, serum was separated and splenocyte suspension was prepared, the number of plaques on each slide was counted by agarose slide method, and the volume of the small chamber was calculated. Correct the number of plaque-forming cells per million (1×10 6 ) splenocytes (i.e., the number of PFCs/10 6 splenocytes) according to the volume of the small chamber and the concentration of splenocytes in the mixture, and the results are shown in the table below; Serum lectin was detected, and the results were expressed in log2 titers, and the results are also shown in the table below; in another experiment, 60 mice, weighing 17-22 g, were administered drugs in groups in the same way, modeled by T3 method and immunized with fresh SRBC. After the animals were sacrificed, blood samples were taken, and the E rosette formation experiment was performed with reference to the literature method to observe the E rosette formation rate, that is, the formation rate of erythrocyte rosette-forming cells (ERFC). The results are shown in the table below.

本发明胶囊剂对阴虚小鼠抗体形成细胞的影响(x±SD)The influence (x ± SD) of capsule of the present invention on the antibody formation cell of yin-deficiency mouse

  组别 group   剂量(g/kg) Dose (g/kg)   溶血空斑(PFC数/10<sup>6</sup>脾细胞) Hemolytic plaques (number of PFCs/10<sup>6</sup> splenocytes)   血清凝集素(log2滴度) Serum agglutinin (log2 titer)   ERFC(%) ERFC(%)   对照组 control group   - -   646.6±298.1 646.6±298.1   4.6±0.7 4.6±0.7   14.3±5.1 14.3±5.1   造型组 Styling group   - -   354.7±105.8 354.7±105.8   3.3±0.5 3.3±0.5   11.4±5.3 11.4±5.3   本发明胶囊剂 Capsules of the present invention   1 1   1043.9±164.8 1043.9±164.8   3.8±0.6 3.8±0.6   18.3±7.4 18.3±7.4   麦味地黄丸 Mai Wei Di Huang Wan   2 2   1044.9±448.9 1044.9±448.9   3.7±0.9 3.7±0.9   17.0±4.7 17.0±4.7

上述结果表明:各给药组均能使阴虚小鼠空斑形成细胞数目明显升高;使阴虚小鼠血清凝集素恢复到正常水平。增加阴虚小鼠E花结形成率。另外本发明胶囊剂组与麦味地黄丸组比较均有显著性差异(P<0.05)故本发明胶囊剂1g/kg剂量组与市售麦味地黄丸2g/kg剂量组疗效相当。The above results show that: each administration group can significantly increase the number of plaque-forming cells in the Yin-deficiency mice, and restore the serum lectin of the Yin-deficiency mice to the normal level. Increase the rosette formation rate of E in yin-deficiency mice. In addition, there is a significant difference between the capsule group of the present invention and the Maiwei Dihuang Wan group (P<0.05), so the curative effect of the 1 g/kg dosage group of the capsule of the present invention is equivalent to that of the commercially available Maiwei Dihuang Wan 2 g/kg dosage group.

本发明实验3:本发明制剂对肺间质纤维化大鼠细胞因子网络的干预作用Experiment 3 of the present invention: the intervention effect of the preparation of the present invention on the cytokine network of rats with pulmonary interstitial fibrosis

一、材料与方法1. Materials and methods

1、动物及分组:清洁级SD雄性大鼠48只,体重180~210g。完全随机分成4个组,每组12只,分别为:I组:空白对照组,II组:模型组,III组:本发明滴丸组,按照本发明方法制备。IV组:麦味地黄丸(浓缩丸),市售。1. Animals and grouping: 48 clean-grade SD male rats, weighing 180-210 g. Divide into 4 groups completely at random, every group of 12 is respectively: I group: blank control group, II group: model group, III group: the dripping pill group of the present invention, prepare according to the method of the present invention. Group IV: Maiwei Dihuang Wan (concentrated pill), commercially available.

2、药品:盐酸博来霉素。2. Drugs: bleomycin hydrochloride.

3、动物处理:采用博来霉素气管内注入法。各组以1%戊巴比妥钠(0.4ml/100g体重)经腹腔内注射麻醉,将大鼠仰卧位固定,在无菌操作下行颈部正中切口,逐层分离软组织,暴露气管,经穿刺向气管内缓慢注入博来霉素5mg/kg体重,注入后立即旋转动物,缝合切口。对照组同法支气管内注入等量生理盐水。各治疗组药物用无菌生理盐水配成浓度为6%溶液。于造模后当天开始,按1ml/100g的剂量给已制成的肺纤维化动物灌胃,1次/d。对照组和模型组同法胃内灌注等量生理盐水。于造墨后第7、28天各组6只按前述方法麻醉、固定、切开经不取动脉血。3. Animal treatment: Bleomycin was injected into the trachea. Each group was anesthetized by intraperitoneal injection of 1% sodium pentobarbital (0.4ml/100g body weight), and the rats were fixed in the supine position, and the median neck incision was made under aseptic operation, the soft tissues were separated layer by layer, the trachea was exposed, and the trachea was punctured. Slowly inject bleomycin 5 mg/kg body weight into the trachea, rotate the animal immediately after injection, and suture the incision. The same amount of normal saline was injected into the bronchi of the control group in the same way. The drugs of each treatment group were made into 6% solution with sterile physiological saline. On the day after the modeling, the prepared pulmonary fibrosis animals were given intragastric administration at a dose of 1ml/100g, once a day. The same amount of normal saline was perfused into the stomach of the control group and the model group in the same way. On the 7th and 28th days after ink making, 6 rats in each group were anesthetized, fixed, and incised without taking arterial blood according to the above method.

4、病理组织切片制备:颈总动脉放血后处死动物,取出右侧肺脏投入中性福尔马林液中固定,在外侧行矢状切面,包埋,切片(5um)。行HE染色。4. Preparation of pathological tissue slices: Animals were sacrificed after bloodletting from the common carotid artery, the right lung was taken out and fixed in neutral formalin, sagittal section was made on the outside, embedded, and sliced (5um). Line HE staining.

5、检测:采用放免法测定血浆TXB2、ET-1,ET-1。采用双抗体夹心酶联免疫法测定血清MCP-1。各组数据应用SPSS11.0进行方差分析,并进行两两比较,P<0.05为有显著性差异。5. Detection: Plasma TXB 2 , ET-1, and ET-1 were determined by radioimmunoassay. Serum MCP-1 was measured by double antibody sandwich ELISA. The data of each group was analyzed by variance using SPSS11.0, and pairwise comparisons were made, and P<0.05 was considered to have a significant difference.

二、结果:2. Results:

1、血浆TXB2 1. Plasma TXB 2

各实验组大鼠血浆TXB2含量(pg/ml,x±s)Plasma TXB 2 content of rats in each experimental group (pg/ml, x±s)

  组别 group   剂量(g/kg) Dose (g/kg)   n n   7d 7d   28d 28d   空白对照组 Blank control group   - -   6 6   107.622±16.471 107.622±16.471   109.100±16.905 109.100±16.905   模型组 model group   - -   6 6   233.734±19.256 233.734±19.256   250.794±23.108 250.794±23.108   本发明滴丸组 Dropping pills of the present invention   1g/kg 1g/kg   6 6   116.729±20.094 116.729±20.094   159.319±44.574 159.319±44.574   麦味地黄丸组 Maiwei Dihuang Wan Group   3g/kg 3g/kg   6 6   166.448±40.189 166.448±40.189   226.607±36.105 226.607±36.105

2、血浆ET-12. Plasma ET-1

各实验组大鼠血浆ET-1含量(pg/ml,x±s)Plasma ET-1 content of rats in each experimental group (pg/ml, x±s)

  组别 group   剂量(g/kg) Dose (g/kg)   n n   7d 7d   28d 28d   空白对照组 Blank control group   - -   6 6   51.523±10.276 51.523±10.276   51.515±10.445 51.515±10.445   模型组 model group   - -   6 6   75.987±10.128 75.987±10.128   102.101±17.840 102.101±17.840   本发明滴丸组 Dropping pills of the present invention   1g/kg 1g/kg   6 6   50.541±12.802 50.541±12.802   50.311±4.499 50.311±4.499   麦味地黄丸组 Maiwei Dihuang Wan Group   3g/kg 3g/kg   6 6   65.990±16.473 65.990±16.473   67.912±11.842 67.912±11.842

3、血清MCP-13. Serum MCP-1

各实验组大鼠血清MCP-1含量(pg/ml,x±s)Serum MCP-1 content of rats in each experimental group (pg/ml, x±s)

  组别 group   剂量(g/kg) Dose (g/kg)   n n   7d 7d   28d 28d   空白对照组 Blank control group   - -   6 6   10.895±1.748 10.895±1.748   10.484±1.528 10.484±1.528   模型组 model group   - -   6 6   24.046±5.55 24.046±5.55   43.772±22.378 43.772±22.378   本发明滴丸组 Dropping pills of the present invention   1g/kg 1g/kg   6 6   11.959±6.729 11.959±6.729   15.188±1.931 15.188±1.931   麦味地黄丸组 Maiwei Dihuang Wan Group   3g/kg 3g/kg   6 6   20.218±8.308 20.218±8.308   28.692±3.887 28.692±3.887

根据以上实验结果,由于治疗组间有显著性差异(P<0.05),故本发明滴丸组与市售麦味地黄丸(浓缩丸)组比较,在临床用量相同的情况下,本发明滴丸组对比市售麦味地黄丸的疗效更好,生物利用度更高。According to the above experimental results, since there is a significant difference (P<0.05) between the treatment groups, the dripping pills group of the present invention is compared with the commercially available Maiwei Dihuang Pills (concentrated pills) group. Compared with the commercially available Maiwei Dihuang Wan, the pill group has better curative effect and higher bioavailability.

具体实施方式: Detailed ways:

本发明实施例1:称取:麦冬30g、五味子(制)80g、熟地黄80g、山茱萸(制)160g、牡丹皮30g、山药40g、茯苓120g、泽泻30g、豆油75ml、吐温-8040ml、乙基纤维素50g;制备工艺为:茯苓粉碎成150目的细粉,牡丹皮加入300ml水,改良油水分离器中加2.5%的醋酸乙酯,蒸馏提取14h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,低温干燥,研成细粉即得牡丹皮提取物;麦冬、五味子、山茱萸用4050ml 80%乙醇回流提取5次,分别为:5h、1h、0.5h、0.5h、0.5h,滤过、合并滤液并浓缩成浸膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与山药、熟地黄、泽泻加入1500ml水煎煮5次,分别为:5h、3h、1h、1h、1h,提取液滤过,合并滤液,浓缩成浸膏,再加入上述麦冬、五味子、山茱萸浸膏,茯苓粉混合均匀,干燥,粉碎成100目的细粉,加入丹皮酚混合均匀,另取豆油、吐温-80、乙基纤维素混匀,将上述药粉加入到豆油、吐温-80和乙基纤维素的混合溶液中混合均匀,制丸,即得软胶囊剂。Example 1 of the present invention: Weighing: Ophiopogon japonicus 30g, Schisandra chinensis (made) 80g, Rehmannia glutinosa 80g, Cornus officinalis (made) 160g, Moutan bark 30g, Chinese yam 40g, Poria cocos 120g, Alisma 30g, soybean oil 75ml, Tween-8040ml , ethyl cellulose 50g; the preparation process is: Poria cocos is crushed into 150-mesh fine powder, Moutan cortex is added to 300ml of water, 2.5% ethyl acetate is added to the improved oil-water separator, distillation is extracted for 14 hours, and the volatile oil in the distillate is extracted , recover ethyl acetate under reduced pressure, dry at low temperature, and grind into fine powder to obtain Moutan Cortex extract; Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis were reflux extracted with 4050ml 80% ethanol for 5 times, respectively: 5h, 1h, 0.5h, 0.5h , 0.5h, filter, combine the filtrate and concentrate into extract, add the aqueous solution and dregs after the distillation of Moutan cortex, dregs after ethanol extraction of Ophiopogon japonicus, Schisandra, and Cornus officinalis, yam, rehmannia glutinosa, and Alisma, add 1500ml of water to decoct Boil 5 times, respectively: 5h, 3h, 1h, 1h, 1h, filter the extract, combine the filtrate, concentrate into an extract, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis extract, Poria powder, mix well, dry, and crush Make into 100 mesh fine powder, add paeonol and mix evenly, take soybean oil, Tween-80, ethyl cellulose and mix evenly, add the above powder into the mixed solution of soybean oil, Tween-80 and ethyl cellulose and mix Evenly, pelletized to obtain soft capsules.

本发明实施例2:称取:麦冬60g、五味子(制)40g、熟地黄160g、山茱萸(制)80g、牡丹皮60g、山药80g、茯苓60g、泽泻60g、微粉纤维素45g、硅藻土20g;制备工艺为:茯苓30g粉碎成100目的细粉;牡丹皮加入300ml水,改良油水分离器中加1.0%的醋酸乙酯,蒸馏提取8h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,低温干燥,研成细粉即得;麦冬、五味子、山茱萸分别用1440ml 60%乙醇回流提取2次,每次2小时,滤过、合并滤液并浓缩成浸膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻加入990ml水煎煮3次,分别为3h、2h、1h,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50%的乙醇进行洗脱,回收乙醇,浓缩成浸膏,再加入上述麦冬、五味子、山茱萸浸膏,茯苓粉混合均匀,干燥,粉碎成100目的细粉,加入丹皮酚混合均匀;取药物粉末200g与微粉纤维素45g、硅藻土20g混合,置包衣制粒机中,以5%乙基甲基纤维素乙醇溶液为粘合剂首先制成40目的母粒,烘干后再放入包衣制粒机的转盘内,再以8%羧甲基纤维素钠水溶液为粘合剂,加混合后的药粉滚动制成粒径为2mm的微丸,干燥,装入胶囊,即得缓释胶囊。工艺参数为:喷浆速度:15r/min,主机转速:80r/min,供粉速度:15r/min。Example 2 of the present invention: Weighing: Ophiopogon japonicus 60g, Schisandra chinensis (made) 40g, Rehmannia glutinosa 160g, Cornus officinalis (made) 80g, Moutan cortex 60g, Chinese yam 80g, Poria cocos 60g, Alisma 60g, micronized cellulose 45g, diatom 20g of soil; the preparation process is: 30g of poria cocos is crushed into 100-mesh fine powder; Moutan cortex is added to 300ml of water, and 1.0% ethyl acetate is added to the improved oil-water separator, and distillation is extracted for 8 hours. Recover ethyl acetate, dry it at low temperature, and grind it into fine powder; Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis were respectively extracted twice with 1440ml 60% ethanol under reflux, each time for 2 hours, filtered, combined and concentrated into an extract, and peony The aqueous solution and dregs after distillation of the bark, the dregs after ethanol extraction of Ophiopogon japonicus, Schisandra, and Cornus officinalis, and the remaining Poria cocos, yam, Rehmannia glutinosa, and Alisma were added to 990ml of water and decocted for 3 times, respectively for 3h, 2h, and 1h, and extracted Filtrate the liquid, combine the filtrates, pass through a macroporous adsorption resin column, elute with 50% ethanol, reclaim the ethanol, concentrate it into an extract, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis extract, and Poria powder, mix evenly, and dry. Grind into 100-mesh fine powder, add paeonol and mix evenly; take 200g of drug powder, mix with 45g of micropowder cellulose, and 20g of diatomaceous earth, put it in a coating granulator, and use 5% ethyl methylcellulose ethanol solution as The binder is first made into 40-mesh masterbatch, and then put into the turntable of the coating granulator after drying, then use 8% sodium carboxymethylcellulose aqueous solution as the binder, add the mixed medicine powder and roll to make it Micropills with a particle size of 2 mm are dried and packed into capsules to obtain sustained-release capsules. The process parameters are: spraying speed: 15r/min, host speed: 80r/min, powder supply speed: 15r/min.

本发明实施例3:称取:麦冬120g、五味子(制)20g、熟地黄320g、山茱萸(制)40g、牡丹皮120g、山药160g、茯苓30g、泽泻120g、β-环糊精40g、PVPP 57g、CMC-Ca 108g、微粉硅胶3g、MCC 200g、硬脂酸镁5g;制备工艺为:茯苓6g粉碎成120目的细粉;牡丹皮加入960ml水,用水蒸汽蒸馏法提取,蒸馏液用β-环糊精进行包合,包合方法为饱和水溶液法,包合温度为35-40℃,超声时间为30min;包合物低温干燥,粉碎成细粉即得;麦冬、五味子、山茱萸用1800ml 70%乙醇回流提取3次,每次1小时,滤过,合并滤液并浓缩成浸膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻加入5000ml水煎煮3次,分别为:3h、2h、1h,提取液滤过,合并滤液,通过大孔吸附树脂柱,用80%的乙醇进行洗脱,回收乙醇,浓缩成浸膏,再加入上述麦冬、五味子、山茱萸浸膏,茯苓粉,丹皮酚环糊精包合物,PVPP 30g,CMC-Ca 60g混合均匀,干燥,粉碎,过100目筛,备用;另取剩余PVPP27g、CMC-Ca48g与微粉硅胶、MCC、硬脂酸镁分别在40℃以下干燥6小时,粉碎,过100目筛,备用;取剩余的PVPP,CMC-Ca、MCC、微粉硅胶与上述药粉混合均匀,以HPMC为黏合剂制软材,过30目筛制剂,60℃干燥2小时后,加入硬脂酸镁混合均匀,压片即得分散片。Example 3 of the present invention: Weighing: Ophiopogon japonicus 120g, Schisandra chinensis (made) 20g, Rehmannia glutinosa 320g, Cornus officinalis (made) 40g, Moutan cortex 120g, Chinese yam 160g, Poria cocos 30g, Alisma 120g, β-cyclodextrin 40g, PVPP 57g, CMC-Ca 108g, micropowder silica gel 3g, MCC 200g, magnesium stearate 5g; the preparation process is as follows: Poria cocos 6g is crushed into 120 mesh fine powder; Moutan cortex is added to 960ml water, extracted by steam distillation, and the distillate is β -Cyclodextrin for inclusion, the inclusion method is a saturated aqueous solution method, the inclusion temperature is 35-40 ° C, and the ultrasonic time is 30 minutes; the inclusion compound is dried at low temperature and crushed into fine powder; used for Ophiopogon japonicus, Schisandra, and Cornus officinalis 1800ml 70% ethanol reflux extraction 3 times, each time for 1 hour, filter, combine the filtrate and concentrate into an extract, distill the aqueous solution and dregs of Moutan cortex, extract dregs and residues of Ophiopogon japonicus, Schisandra, and Cornus officinalis with alcohol Poria cocos, Chinese yam, Rehmannia glutinosa, and Alisma were added to 5000ml water and decocted for 3 times, respectively: 3h, 2h, 1h, the extract was filtered, the combined filtrate was passed through a macroporous adsorption resin column, and eluted with 80% ethanol , recover ethanol, concentrate into extract, then add above-mentioned Ophiopogon japonicus, Schisandra chinensis, Cornus officinalis extract, Poria cocos powder, paeonol cyclodextrin inclusion complex, PVPP 30g, CMC-Ca 60g, mix well, dry, pulverize, pass 100 Mesh sieve, set aside; take the remaining PVPP27g, CMC-Ca48g and micropowder silica gel, MCC, magnesium stearate respectively, dry at 40°C for 6 hours, pulverize, pass through a 100 mesh sieve, set aside; take the remaining PVPP, CMC-Ca, Mix MCC, micropowder silica gel and the above drug powder evenly, use HPMC as a binder to make a soft material, pass through a 30-mesh sieve, dry at 60°C for 2 hours, add magnesium stearate, mix evenly, and press into tablets to obtain dispersible tablets.

本发明实施例4:称取:麦冬60g、五味子(制)40g、熟地黄160g、山茱萸(制)80g、牡丹皮60g、山药80g、茯苓60g、泽泻60g、β-环糊精20g、聚乙二醇4000或聚乙二醇6000300ml;制备工艺为:取茯苓粉碎成80目的细粉;再将其放置在超微粉碎设备中继续粉碎至200目的微粉;牡丹皮用水蒸汽蒸馏萃取,方法为:加入480ml水,改良油水分离器中加2.0%的醋酸乙酯,蒸馏提取10h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,蒸馏液用β-环糊精进行包合,包合温度为35℃,超声时间为30min。包合物低温干燥,粉碎成细粉即得;麦冬、五味子、山茱萸加入1080ml 95%乙醇回流提取2次,每次1小时、滤过、合并滤液并浓缩成清膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与山药、熟地黄、泽泻加入2400ml水煎煮3次,煎煮时间分别为3h、2h、1h,提取液滤过,合并滤液,通过大孔吸附树脂柱,用70%的乙醇进行洗脱,回收乙醇,浓缩成清膏,再加入上述麦冬、五味子、山茱萸清膏和茯苓微粉混合制粒,干燥,再与丹皮酚环糊精包合物混合均匀,将所得的药粉或颗粒加入已经加热熔融的聚乙二醇4000或聚乙二醇6000中,保持恒定温度90-102℃,用滴管滴入甲基硅油中,即得滴丸制剂。Example 4 of the present invention: Weighing: Ophiopogon japonicus 60g, Schisandra chinensis (made) 40g, Rehmannia glutinosa 160g, Cornus officinalis (made) 80g, Moutan cortex 60g, Chinese yam 80g, Poria cocos 60g, Alisma 60g, β-cyclodextrin 20g, Polyethylene glycol 4000 or polyethylene glycol 6000-300ml; the preparation process is as follows: take poria cocos and pulverize it into 80-mesh fine powder; then place it in an ultra-fine pulverization equipment and continue pulverizing it into 200-mesh micropowder; Moutan cortex is distilled and extracted with water. Method: add 480ml of water, add 2.0% ethyl acetate to the improved oil-water separator, distill and extract for 10 hours, extract the volatile oil in the distillate, recover ethyl acetate under reduced pressure, and use β-cyclodextrin for inclusion in the distillate , the inclusion temperature is 35°C, and the ultrasonic time is 30min. The clathrate is dried at low temperature and crushed into fine powder; Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis are extracted by adding 1080ml 95% ethanol to reflux for 2 times, each time for 1 hour, filtering, combining the filtrates and concentrating them into a clear paste, distilling Moutan bark The aqueous solution and dregs of Ophiopogon japonicus, Schisandra chinensis, Cornus officinalis ethanol extracted dregs, Chinese yam, rehmannia glutinosa, and Alisma are added to 2400ml of water and decocted for 3 times. The decoction time is 3h, 2h, 1h respectively, and the extract is filtered. Combine the filtrates, pass through a macroporous adsorption resin column, elute with 70% ethanol, recover the ethanol, concentrate into a clear paste, add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis clear paste and Poria micropowder, mix and granulate, dry, and then mix with dandelion Mix the skinphenol-cyclodextrin inclusion complex evenly, add the obtained powder or granules into the polyethylene glycol 4000 or polyethylene glycol 6000 that has been heated and melted, keep a constant temperature of 90-102°C, drop the methyl alcohol with a dropper In silicone oil, drop pill preparations are obtained.

本发明实施例5:称取:麦冬60g、五味子(制)40g、熟地黄160g、山茱萸(制)80g、牡丹皮60g、山药80g、茯苓60g、泽泻60g、α-环糊精20g、硬脂酸钠或甘油明胶300ml;制备工艺为:取茯苓粉碎成100目的细粉;再将其放置在超微粉碎设备中继续粉碎至300目的微粉;牡丹皮用水蒸汽蒸馏萃取,方法为:加入480ml水,改良油水分离器中加2.0%的醋酸乙酯,蒸馏提取10h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,蒸馏液用α-环糊精进行包合,包合温度为35℃,超声时间为30min。包合物低温干燥,粉碎成细粉即得;麦冬、五味子、山茱萸加入1080ml 95%乙醇回流提取2次,每次1小时、滤过、合并滤液并浓缩成清膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与山药、熟地黄、泽泻加入2400ml水煎煮3次,煎煮时间分别为3h、2h、1h,提取液滤过,合并滤液,通过大孔吸附树脂柱,用70%的乙醇进行洗脱,回收乙醇,浓缩成清膏,再加入上述麦冬、五味子、山茱萸清膏和茯苓微粉混合制粒,干燥,再与丹皮酚环糊精包合物混合均匀,将所得的药粉或颗粒加入已经加热熔融的硬脂酸钠或甘油明胶基质中,保持恒定温度78-90℃,用滴管滴入甲基硅油中,即得滴丸制剂。Example 5 of the present invention: Weighing: Ophiopogon japonicus 60g, Schisandra chinensis (made) 40g, Rehmannia glutinosa 160g, Cornus officinalis (made) 80g, Moutan cortex 60g, Chinese yam 80g, Poria cocos 60g, Alisma 60g, α-cyclodextrin 20g, Sodium stearate or glycerin gelatin 300ml; the preparation process is: take poria cocos and pulverize it into a fine powder of 100 mesh; then place it in an ultra-fine pulverization equipment and continue pulverizing it into a fine powder of 300 mesh; distill and extract Moutan cortex with water steam, the method is: add 480ml of water, add 2.0% ethyl acetate to the improved oil-water separator, distill and extract for 10 hours, extract the volatile oil in the distillate, recover ethyl acetate under reduced pressure, and use α-cyclodextrin for inclusion in the distillate. The temperature is 35°C, and the ultrasonic time is 30min. The clathrate is dried at low temperature and crushed into fine powder; Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis are extracted by adding 1080ml 95% ethanol to reflux for 2 times, each time for 1 hour, filtering, combining the filtrates and concentrating them into a clear paste, distilling Moutan bark The aqueous solution and dregs of Ophiopogon japonicus, Schisandra chinensis, Cornus officinalis ethanol extracted dregs, Chinese yam, rehmannia glutinosa, and Alisma are added to 2400ml of water and decocted for 3 times. The decoction time is 3h, 2h, 1h respectively, and the extract is filtered. Combine the filtrates, pass through a macroporous adsorption resin column, elute with 70% ethanol, recover the ethanol, concentrate into a clear paste, add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis clear paste and Poria micropowder, mix and granulate, dry, and then mix with dandelion Mix the skinphenol cyclodextrin inclusion compound evenly, add the obtained medicinal powder or granules into the heated and melted sodium stearate or glycerin gelatin base, keep a constant temperature of 78-90°C, drop into the methyl silicone oil with a dropper, That is the drop pill preparation.

本发明实施例6:称取:麦冬60g、五味子(制)40g、熟地黄160g、山茱萸(制)80g、牡丹皮60g、山药80g、茯苓60g、泽泻60g;制备工艺为:茯苓30g粉碎成120目的细粉;牡丹皮用水蒸汽蒸馏萃取丹皮酚,方法为牡丹皮加入480ml水,改良油水分离器中加2.0%的醋酸乙酯,蒸馏提取10h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,即得;麦冬、五味子、山茱萸用乙醇回流提取3次,提取时间分别为1h、0.5h、0.5h、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻加入3300ml水煎煮5小时,提取液滤过,通过大孔吸附树脂柱,用50%的乙醇进行洗脱,回收乙醇,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏、茯苓粉混合制粒,微波干燥,粉碎,装入胶囊,即得胶囊制剂。Embodiment 6 of the present invention: Weigh: Ophiopogon japonicus 60g, Schisandra chinensis (made) 40g, Rehmannia glutinosa 160g, Cornus officinalis (made) 80g, Moutan cortex 60g, Chinese yam 80g, Poria cocos 60g, Alisma 60g; The preparation process is: Poria cocos 30g pulverized Become 120 mesh fine powder; Cortex Moutan extracts paeonol with steam distillation, method is to add 480ml water to Cortex Moutan, add 2.0% ethyl acetate in the improved oil-water separator, distill and extract 10h, after extracting the volatile oil in the distillate, Ethyl acetate was recovered under reduced pressure to obtain it; Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis were extracted 3 times with ethanol reflux, the extraction time was 1h, 0.5h, and 0.5h, respectively, filtered, and the filtrates were combined and concentrated to a thick paste. Add the distilled aqueous solution, the dregs of Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis ethanol, and the remaining Poria cocos, Chinese yam, Rehmannia glutinosa, and Alisma, into 3300ml of water and decoct for 5 hours, filter the extract, pass through a macroporous adsorption resin column, and use Elute with 50% ethanol, recover ethanol, concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste, Poria powder, mix and granulate, microwave dry, pulverize, pack into capsules, and obtain capsule preparations.

本发明实施例7:称取:麦冬120g、五味子(制)20g、熟地黄320g、山茱萸(制)40g、牡丹皮120g、山药160g、茯苓30g、泽泻120g、糊精或蔗糖2000g;制备工艺为:茯苓粉碎成100目的细粉,牡丹皮用水蒸汽蒸馏,方法为:牡丹皮加入720ml水,改良油水分离器中加2.0%的醋酸乙酯,蒸馏提取10h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,低温干燥,研成细粉即得;麦冬、五味子、山茱萸用乙醇提取、滤过、滤液浓缩至稠膏状;将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻加水煎煮,提取液滤过,合并滤液,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏,丹皮酚以及糊精或蔗糖混合均匀,制粒,即得颗粒制剂。Example 7 of the present invention: Weighing: Ophiopogon japonicus 120g, Schisandra chinensis (made) 20g, Rehmannia glutinosa 320g, Cornus officinalis (made) 40g, Moutan cortex 120g, Chinese yam 160g, Poria cocos 30g, Alisma 120g, dextrin or sucrose 2000g; preparation The process is: Poria cocos is crushed into 100-mesh fine powder, and the cortex of Moutan is steam distilled. The method is: add 720ml of water to the cortex of Moutan, add 2.0% ethyl acetate to the improved oil-water separator, distill and extract for 10 hours, and extract the volatile oil in the distillate Finally, recover ethyl acetate under reduced pressure, dry it at low temperature, and grind it into fine powder to get it; extract Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis with ethanol, filter, and concentrate the filtrate to a thick paste; distill the aqueous solution and dregs of Moutan cortex, The dregs extracted by ethanol from Ophiopogon japonicus, Schisandra, and Cornus officinalis, and the remaining Poria cocos, Chinese yam, rehmannia glutinosa, and Alisma, add water to decoct, filter the extract, combine the filtrate, concentrate to a thick paste, and then add the above-mentioned Ophiopogon japonicus, Schisandra, The dogwood thick paste, paeonol and dextrin or sucrose are evenly mixed and granulated to obtain a granule preparation.

本发明实施例8:称取:麦冬30g、五味子(制)80g、熟地黄80g、山茱萸(制)160g、牡丹皮30g、山药40g、茯苓120g、泽泻30g、甜味剂或乳糖320g;制备工艺为:牡丹皮用水蒸汽蒸馏,方法为:牡丹皮加入240ml水,改良油水分离器中加1.5%的醋酸乙酯,蒸馏提取10h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,低温干燥,研成细粉即得;麦冬、五味子、山茱萸用乙醇回流提取4次,每次0.5小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与茯苓、山药、熟地黄、泽泻加入1620ml水煎煮3次,分别煎煮3h、1h、1h,提取液滤过,合并滤液,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏,丹皮酚以及甜味剂或乳糖混匀,制粒,即得颗粒剂。Example 8 of the present invention: Weighing: Ophiopogon japonicus 30g, Schisandra chinensis (made) 80g, Rehmannia glutinosa 80g, Cornus officinalis (made) 160g, Moutan cortex 30g, Chinese yam 40g, Poria cocos 120g, Alisma 30g, sweetener or lactose 320g; The preparation process is: water steam distillation of Moutan cortex, the method is: add 240ml of water to Moutan cortex, add 1.5% ethyl acetate to the improved oil-water separator, distill and extract for 10 hours, extract the volatile oil in the distillate, and recover ethyl acetate under reduced pressure Esters, dried at low temperature, and ground into fine powder to obtain; Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis were extracted with ethanol reflux 4 times, each time for 0.5 hours, filtered, combined filtrates and concentrated to a thick paste, distilled aqueous solution of Moutan bark and Dregs, dregs extracted by ethanol from Ophiopogon japonicus, Schisandra, Cornus officinalis, Poria cocos, Chinese yam, Rehmannia glutinosa, and Alisma, add 1620ml of water to decoct 3 times, decoct for 3 hours, 1 hour, 1 hour respectively, filter the extract, combine the filtrate, Concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, schisandra, dogwood thick paste, paeonol and sweetener or lactose, mix evenly, and granulate to obtain granules.

本发明实施例9:称取:麦冬120g、五味子(制)20g、熟地黄320g、山茱萸(制)40g、牡丹皮120g、山药160g、茯苓30g、泽泻120g、炼蜜250g;制备工艺为:茯苓9g粉碎成100目以上的细粉;牡丹皮用水蒸汽蒸馏,方法为:牡丹皮加入1080ml水,改良油水分离器中加2.5%的醋酸乙酯,蒸馏提取8h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,低温干燥,研成细粉即得。麦冬、五味子、山茱萸用2700ml 90%乙醇回流提取5小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻用水煎煮,第一次加入6210ml水煎煮3小时,第二至五次分别4968ml水煎煮1小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用80%的乙醇进行洗脱,回收乙醇,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏和茯苓粉混合,进行喷雾干燥,粉碎,过60目的筛网,加入丹皮酚混合均匀,再加入炼蜜合药,制成蜜丸即得丸剂。Embodiment 9 of the present invention: Weighing: Ophiopogon japonicus 120g, Schisandra chinensis (made) 20g, Rehmannia glutinosa 320g, Cornus officinalis (made) 40g, Moutan cortex 120g, Chinese yam 160g, Poria cocos 30g, Alisma 120g, refined honey 250g; The preparation process is Poria cocos 9g is ground into the fine powder of more than 100 orders; Cortex Moutan is steam distilled, and method is: Cortex Moutan adds 1080ml water, adds 2.5% ethyl acetate in the improved oil-water separator, distills and extracts for 8h, extracts the After volatile oil, recover ethyl acetate under reduced pressure, dry at low temperature, and grind into fine powder. Radix Ophiopogon japonicus, schisandra, and dogwood were extracted with 2700ml of 90% ethanol for 5 hours, filtered, combined and concentrated to a thick paste, and the distilled aqueous solution and dregs of Moutan cortex, and the medicine after ethanol extraction of Ophiopogon japonicus, Schisandra, and dogwood Decoct the slag and the remaining Poria cocos, yam, rehmannia glutinosa, and Alisma in water, add 6210ml of water for 3 hours for the first time, and decoct for 1 hour with 4968ml of water for the second to fifth times, filter the extract, combine the filtrate, and pass Macroporous adsorption resin column, elute with 80% ethanol, recover ethanol, concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste and Poria powder, spray dry, pulverize, and pass through a 60-mesh sieve Net, add paeonol and mix evenly, then add refined honey and medicine to make honeyed pills to get pills.

本发明实施例10:称取:麦冬120g、五味子(制)20g、熟地黄320g、山茱萸(制)40g、牡丹皮120g、山药160g、茯苓30g、泽泻120g、炼蜜75g;制备工艺为:茯苓9g粉碎成100目以上的细粉;牡丹皮用水蒸汽蒸馏,方法为:牡丹皮加入720ml水,改良油水分离器中加1.0%的醋酸乙酯,蒸馏提取12h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,低温干燥,研成细粉即得。麦冬、五味子、山茱萸用2700ml 90%乙醇回流提取5小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻用水煎煮,第一次加入6210ml水煎煮3小时,第二至五次分别4968ml水煎煮1小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用80%的乙醇进行洗脱,回收乙醇,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏和茯苓粉混合,进行喷雾干燥,粉碎,过60目的筛网,加入丹皮酚混合均匀,再加入炼蜜合药,制成蜜丸即得丸剂。Example 10 of the present invention: Weighing: Ophiopogon japonicus 120g, Schisandra chinensis (made) 20g, Rehmannia glutinosa 320g, Cornus officinalis (made) 40g, Moutan cortex 120g, Chinese yam 160g, Poria cocos 30g, Alisma 120g, refined honey 75g; The preparation process is Poria cocos 9g is pulverized into fine powder more than 100 orders; Cortex Moutan is steam distilled, and method is: Cortex Moutan adds 720ml water, adds 1.0% ethyl acetate in the improved oil-water separator, distills and extracts for 12h, extracts the After volatile oil, recover ethyl acetate under reduced pressure, dry at low temperature, and grind into fine powder. Radix Ophiopogon japonicus, schisandra, and dogwood were extracted with 2700ml of 90% ethanol for 5 hours, filtered, combined and concentrated to a thick paste, and the distilled aqueous solution and dregs of Moutan cortex, and the medicine after ethanol extraction of Ophiopogon japonicus, Schisandra, and dogwood Decoct the slag and the remaining Poria cocos, yam, rehmannia glutinosa, and Alisma in water, add 6210ml of water for 3 hours for the first time, and decoct for 1 hour with 4968ml of water for the second to fifth times, filter the extract, combine the filtrate, and pass Macroporous adsorption resin column, elute with 80% ethanol, recover ethanol, concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste and Poria powder, spray dry, pulverize, and pass through a 60-mesh sieve Net, add paeonol and mix evenly, then add refined honey and medicine to make honeyed pills to get pills.

本发明实施例11:称取:麦冬30g、五味子(制)80g、熟地黄80g、山茱萸(制)160g、牡丹皮30g、山药40g、茯苓120g、泽泻30g、γ-环糊精5g、淀粉28.5g、硬脂酸镁0.73g;制备工艺为:茯苓96g粉碎成150目的细粉;牡丹皮用水蒸汽蒸馏,蒸馏萃取方法为,药材加300ml水,改良油水分离器中加2.5%的醋酸乙酯,蒸馏提取8h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,即得。蒸馏液用γ-环糊精进行包合,包合温度为35-40℃,超声时间为30-35min。包合物低温干燥,粉碎成细粉即得;麦冬、五味子、山茱萸用乙醇回流提取3次,每次1小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻分别加入522ml水煎煮2次,每次2小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用60%的乙醇进行洗脱,回收乙醇,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏和茯苓粉混合,进行喷雾干燥,加入淀粉和上述丹皮酚环糊精包合物混匀,用乙醇制粒,再加入硬脂酸镁混匀,压片,用2%薄膜包衣剂对素片进行包衣,即得片剂。Example 11 of the present invention: Weighing: Ophiopogon japonicus 30g, Schisandra chinensis (made) 80g, Rehmannia glutinosa 80g, Cornus officinalis (made) 160g, Moutan cortex 30g, Chinese yam 40g, Poria cocos 120g, Alisma 30g, γ-cyclodextrin 5g, 28.5g of starch and 0.73g of magnesium stearate; the preparation process is as follows: 96g of poria cocos is crushed into a fine powder of 150 mesh; Moutan cortex is steam distilled, and the distillation extraction method is as follows: add 300ml of water to the medicinal material, and add 2.5% acetic acid to the improved oil-water separator Ethyl, distilled and extracted for 8 hours, after extracting the volatile oil in the distillate, recover ethyl acetate under reduced pressure, that is. The distillate is clathrated with γ-cyclodextrin, the clathrate temperature is 35-40°C, and the ultrasonic time is 30-35min. The clathrate is dried at low temperature and crushed into fine powder; Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis are extracted with ethanol reflux 3 times, each time for 1 hour, filtered, combined filtrates and concentrated to a thick paste, and the aqueous solution distilled from Moutan bark and dregs of Ophiopogon japonicus, Schisandra chinensis, Cornus officinalis after ethanol extraction and remaining Poria cocos, Chinese yam, Rehmannia glutinosa, and Alisma, add 522ml of water to decoct twice, each time for 2 hours, filter the extract, combine the filtrate, Pass through a macroporous adsorption resin column, elute with 60% ethanol, recover ethanol, concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste and Poria powder, spray dry, add starch and the above-mentioned dandelion The skinphenol-cyclodextrin inclusion compound is mixed evenly, granulated with ethanol, then added with magnesium stearate, mixed evenly, pressed into tablets, and coated with a 2% film coating agent to obtain tablets.

本发明实施例12:称取:麦冬30g、五味子(制)80g、熟地黄80g、山茱萸(制)160g、牡丹皮30g、山药40g、茯苓120g、泽泻30g、γ-环糊精30g、淀粉114g、硬脂酸镁1.73g;制备工艺为:茯苓96g粉碎成150目的细粉;牡丹皮用水蒸汽蒸馏,蒸馏萃取方法为,药材加300ml水,改良油水分离器中加2.5%的醋酸乙酯,蒸馏提取8h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,即得。蒸馏液γ-环糊精进行包合,包合温度为35-40℃,超声时间为30-35min。包合物低温干燥,粉碎成细粉即得;麦冬、五味子、山茱萸用乙醇回流提取3次,每次1小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子、山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄、泽泻分别加入522ml水煎煮2次,每次2小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用70%的乙醇进行洗脱,回收乙醇,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏和茯苓粉混合,进行喷雾干燥,加入淀粉和上述丹皮酚环糊精包合物混匀,用乙醇制粒,再加入硬脂酸镁混匀,压片,用8%薄膜包衣剂对素片进行包衣,即得片剂。Example 12 of the present invention: Weighing: Ophiopogon japonicus 30g, Schisandra chinensis (made) 80g, Rehmannia glutinosa 80g, Cornus officinalis (made) 160g, Moutan cortex 30g, Chinese yam 40g, Poria cocos 120g, Alisma 30g, γ-cyclodextrin 30g, 114g of starch and 1.73g of magnesium stearate; the preparation process is as follows: 96g of poria cocos is crushed into a fine powder of 150 mesh; Moutan cortex is steam distilled, and the distillation extraction method is as follows: add 300ml of water to the medicinal material, and add 2.5% ethyl acetate to the improved oil-water separator Esters, distilled and extracted for 8h, after extracting the volatile oil in the distillate, recover ethyl acetate under reduced pressure, that is. The γ-cyclodextrin in the distillate is clathrated, the clathrate temperature is 35-40° C., and the ultrasonic time is 30-35 min. The clathrate is dried at low temperature and crushed into fine powder; Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis are extracted with ethanol reflux 3 times, each time for 1 hour, filtered, combined filtrates and concentrated to a thick paste, and the aqueous solution distilled from Moutan bark and dregs of Ophiopogon japonicus, Schisandra chinensis, Cornus officinalis after ethanol extraction and remaining Poria cocos, Chinese yam, Rehmannia glutinosa, and Alisma, add 522ml of water to decoct twice, each time for 2 hours, filter the extract, combine the filtrate, Pass through a macroporous adsorption resin column, elute with 70% ethanol, recover ethanol, concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste and Poria powder, spray dry, add starch and the above-mentioned dandelion The skinphenol-cyclodextrin inclusion compound is mixed evenly, granulated with ethanol, then added with magnesium stearate, mixed evenly, pressed into tablets, and coated with 8% film coating agent to obtain tablets.

本发明实施例13:称取:麦冬45g、五味子30g、熟地黄120g、山茱萸(制)60g、牡丹皮45g、山药60g、茯苓45g、泽泻45g、蔗糖50g、苯甲酸钠0.6g;牡丹皮用水蒸汽蒸馏,蒸馏萃取方法为,药材加480ml水,改良油水分离器中加2.0%的醋酸乙酯,蒸馏提取10h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,即得;剩下的药物第一次加入5400ml水煎煮4小时,第二次加入4320ml水煎煮2小时,第三次加入3240ml水煎煮1小时,提取液滤过,合并滤液,滤过,滤液浓缩,静置12小时,取上清液,滤过,滤液继续浓缩,冷藏24小时,滤过滤液加入蔗糖,煮沸溶解,滤过,加入苯甲酸钠,加水至全量,搅匀,即得口服液。Example 13 of the present invention: weighing: Ophiopogon japonicus 45g, Schisandra chinensis 30g, Rehmannia glutinosa 120g, Cornus officinalis (made) 60g, Moutan bark 45g, Chinese yam 60g, Poria cocos 45g, Alisma 45g, sucrose 50g, sodium benzoate 0.6g; Moutan bark Distillation with water steam, the distillation extraction method is as follows: add 480ml of water to the medicinal material, add 2.0% ethyl acetate to the improved oil-water separator, distill and extract for 10 hours, extract the volatile oil in the distillate, and recover ethyl acetate under reduced pressure to obtain the product; Add 5400ml of water for the first time to decoct the remaining medicine for 4 hours, add 4320ml of water for the second time and decoct for 2 hours, add 3240ml of water for the third time and decoct for 1 hour, filter the extract, combine the filtrates, filter, and concentrate the filtrate , stand still for 12 hours, take the supernatant, filter, continue to concentrate the filtrate, refrigerate for 24 hours, add sucrose to the filtrate, boil to dissolve, filter, add sodium benzoate, add water to the full amount, stir well, and obtain the oral liquid.

本发明实施例14:称取:麦冬45g、五味子30g、熟地黄120g、山茱萸(制)60g、牡丹皮45g、山药60g、茯苓45g、泽泻45g、蔗糖600g、苯甲酸钠8g;牡丹皮用水蒸汽蒸馏,蒸馏萃取方法为,药材加600ml水,改良油水分离器中加2.0%的醋酸乙酯,蒸馏提取10h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,即得;剩下的药物第一次加入5400ml水煎煮4小时,第二次加入4320ml水煎煮2小时,第三次加入3240ml水煎煮1小时,提取液滤过,合并滤液,滤过,滤液浓缩,静置12小时,取上清液,滤过,滤液继续浓缩,冷藏24小时,滤过滤液加入蔗糖,煮沸溶解,滤过,加入苯甲酸钠,加水至全量,搅匀,即得口服液。Example 14 of the present invention: Weigh: Ophiopogon japonicus 45g, Schisandra 30g, Rehmannia glutinosa 120g, Cornus officinalis (made) 60g, Moutan bark 45g, Chinese yam 60g, Poria cocos 45g, Alisma 45g, sucrose 600g, sodium benzoate 8g; Moutan bark water Steam distillation, the distillation extraction method is as follows: add 600ml of water to the medicinal materials, add 2.0% ethyl acetate to the improved oil-water separator, distill and extract for 10 hours, extract the volatile oil in the distillate, and recover ethyl acetate under reduced pressure to obtain the product; Add 5400ml of water for the first time and decoct for 4 hours, add 4320ml of water for the second time and decoct for 2 hours, add 3240ml of water for the third time and decoct for 1 hour, filter the extract, combine the filtrates, filter, concentrate the filtrate, Stand still for 12 hours, take the supernatant, filter, continue to concentrate the filtrate, refrigerate for 24 hours, add sucrose to the filtrate, boil to dissolve, filter, add sodium benzoate, add water to the full amount, stir well to obtain the oral liquid.

Claims (13)

1. 一种滋肾养肺的中药口服制剂的制备方法,按照重量组份计算:它由麦冬30-120、制五味子20-80、熟地黄80-320、制山茱萸40-160、牡丹皮30-120、山药40-160、茯苓30-120和泽泻30-120及辅料制备而成;其特征在于:茯苓部分或全部粉碎成100目以上的细粉,牡丹皮用水蒸汽蒸馏提取丹皮酚;麦冬、五味子和山茱萸用乙醇提取、滤过、滤液浓缩至稠膏状;将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子和山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄和泽泻加水煎煮,提取液滤过,合并滤液,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏、茯苓粉和丹皮酚混合均匀,最后加入不同的辅料按照不同的方法制成不同的制剂。1. A preparation method of traditional Chinese medicine oral preparation for nourishing kidney and lung, calculated according to weight components: it consists of Radix Ophiopogon 30-120, Schisandra 20-80, Rehmannia glutinosa 80-320, Cornus officinalis 40-160, Cortex Moutan 30-120, Chinese yam 40-160, Poria cocos 30-120, Alisma 30-120 and auxiliary materials; it is characterized in that part or all of Poria cocos is crushed into a fine powder of more than 100 mesh, Moutan bark is steam distilled to extract paeonol phenol; Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis are extracted with ethanol, filtered, and the filtrate is concentrated to a thick paste; the aqueous solution and dregs of Moutan cortex after distillation, the dregs of dregs after ethanol extraction of Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis and the remaining Poria cocos, Chinese yam, Rehmannia glutinosa and Alisma chinensis are decocted with water, the extracts are filtered, the filtrates are combined, and concentrated to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra chinensis, Cornus officinalis thick paste, Poria powder and paeonol and mix well, and finally add different excipients according to Different methods make different formulations. 2. 按照权利要求1所述的滋肾养肺的中药口服制剂的制备方法,其特征在于:茯苓部分或全部粉碎成100目以上的细粉,牡丹皮用水蒸汽蒸馏提取丹皮酚;麦冬、五味子和山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩成浸膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子和山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄和泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,浓缩成浸膏,再加入上述麦冬、五味子、山茱萸浸膏、茯苓粉和丹皮酚混合均匀,最后加入不同的辅料按照不同的方法制成不同的制剂。2. According to the preparation method of the traditional Chinese medicine oral preparation for nourishing the kidney and nourishing the lung according to claim 1, it is characterized in that: Poria cocos is partially or completely pulverized into a fine powder above 100 mesh, paeonol is extracted from Cortex Moutan with steam distillation; Ophiopogon japonicus , Schisandra chinensis and Cornus officinalis are extracted with ethanol reflux 1-5 times, each time for 0.5-5 hours, filtered, combined filtrates and concentrated into an extract, the distilled aqueous solution of Moutan cortex and medicinal residues, Ophiopogon japonicus, Schisandra and Cornus officinalis ethanol extraction Add 3-10 times the amount of water to decoct the remaining medicinal residues, Poria cocos, Chinese yam, Rehmannia glutinosa and Alisma 1-5 times, each time for 1-5 hours, filter the extract, combine the filtrates, concentrate into an extract, and then Add the above-mentioned Ophiopogon japonicus, Schisandra chinensis, Cornus officinalis extract, Poria cocos powder and paeonol and mix evenly, and finally add different auxiliary materials and make different preparations according to different methods. 3. 按照权利要求1或2所述的滋肾养肺的中药口服制剂的制备方法,其特征在于:茯苓部分或全部粉碎成100目以上的细粉;牡丹皮用水蒸汽蒸馏提取丹皮酚;麦冬、五味子和山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩成浸膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子和山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄和泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50-80%的乙醇进行洗脱,回收乙醇,浓缩成浸膏,再加入上述麦冬、五味子、山茱萸浸膏、茯苓粉和丹皮酚混合均匀,再加入不同的辅料按照不同的方法制成不同的制剂。3. According to the preparation method of the Chinese medicine oral preparation for nourishing the kidney and nourishing the lung described in claim 1 or 2, it is characterized in that: Poria cocos is partly or completely pulverized into a fine powder of more than 100 mesh; Moutan cortex is steam distilled to extract paeonol; Radix Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis are extracted with ethanol reflux for 1-5 times, each time for 0.5-5 hours, filtered, combined filtrates and concentrated into an extract, distilled aqueous solution of Moutan cortex and medicinal residues, Ophiopogon japonicus, Schisandra and Cornus officinalis Add 3-10 times the amount of water to decoct the medicinal residue after ethanol extraction and the remaining Poria cocos, yam, Rehmannia glutinosa and Alisma 1-5 times, 1-5 hours each time, filter the extract, combine the filtrate, and absorb through macropores Resin column, eluted with 50-80% ethanol, recovered ethanol, concentrated into extract, then added the above-mentioned Ophiopogon japonicus, Schisandra chinensis, Cornus officinalis extract, Poria powder and paeonol and mixed evenly, then added different auxiliary materials according to different different preparation methods. 4. 按照权利要求1或2所述的滋肾养肺的中药口服制剂的制备方法,其特征在于:茯苓部分或全部粉碎成100目以上的细粉;牡丹皮用水蒸汽蒸馏,蒸馏液用0.5-5倍量的环糊精进行包合,包合物低温干燥,粉碎成细粉即得;麦冬、五味子和山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩成浸膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子和山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄和泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50-80%的乙醇进行洗脱,回收乙醇,浓缩成浸膏,再加入上述麦冬、五味子、山茱萸浸膏、茯苓粉和丹皮酚环糊精包合物混合均匀,再加入不同的辅料按照不同的方法制成不同的制剂。4. According to the preparation method of the traditional Chinese medicine oral preparation for nourishing the kidney and nourishing the lung according to claim 1 or 2, it is characterized in that: Poria cocos is partly or completely pulverized into a fine powder of more than 100 mesh; -5 times the amount of cyclodextrin for inclusion, the inclusion compound is dried at low temperature, and crushed into a fine powder; Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis are extracted 1-5 times with ethanol reflux, each time for 0.5-5 hours, filtered, Combine the filtrates and concentrate them into an extract, add 3-10 times the amount of water to decoct the distilled aqueous solution of Moutan cortex and dregs, ethanol-extracted dregs of Ophiopogon japonicus, Schisandra chinensis, and Cornus officinalis, and the remaining Poria cocos, yam, Rehmannia glutinosa, and Alisma Boil 1-5 times, 1-5 hours each time, filter the extract, combine the filtrate, pass through a macroporous adsorption resin column, elute with 50-80% ethanol, recover the ethanol, concentrate it into an extract, and then add the above Ophiopogon japonicus, Schisandra chinensis, Cornus officinalis extract, Poria cocos powder and paeonol cyclodextrin inclusion compound are mixed evenly, and then different auxiliary materials are added to make different preparations according to different methods. 5. 按照权利要求4所述的滋肾养肺的中药口服制剂的制备方法,其特征在于:本发明中所述环糊精包括α-环糊精、β-环糊精、γ-环糊精。5. According to the preparation method of the traditional Chinese medicine oral preparation for nourishing the kidney and nourishing the lung according to claim 4, it is characterized in that: the cyclodextrin in the present invention includes α-cyclodextrin, β-cyclodextrin, γ-cyclodextrin Refined. 6. 按照权利要求5所述的滋肾养肺的中药口服制剂的制备方法,其特征在于:所述的环糊精为β-环糊精。6. according to the preparation method of the traditional Chinese medicine oral preparation of nourishing the kidney and nourishing the lung described in claim 5, it is characterized in that: described cyclodextrin is β-cyclodextrin. 7. 按照权利要求4所述的滋肾养肺的中药口服制剂的制备方法,其特征在于:蒸馏萃取方法为,药材加5-10倍量水,改良油水分离器中加1.0-2.5%的醋酸乙酯,蒸馏提取8-14h,萃取出蒸馏液中的挥发油后,减压回收醋酸乙酯,即得;所说的挥发油环糊精包合的方法为饱和水溶液法;包合温度为30-40℃,超声时间为25-35min。7. According to the preparation method of the traditional Chinese medicine oral preparation for nourishing the kidney and nourishing the lung according to claim 4, it is characterized in that: the distillation extraction method is that the medicinal material is added with 5-10 times the amount of water, and 1.0-2.5% of the water is added to the improved oil-water separator. Ethyl acetate, distilled and extracted for 8-14h, after extracting the volatile oil in the distillate, recover ethyl acetate under reduced pressure to obtain that; the method of inclusion of the volatile oil cyclodextrin is a saturated aqueous solution method; the inclusion temperature is 30 -40°C, ultrasonic time is 25-35min. 8. 按照权利要求1或2所述的滋肾养肺的中药口服制剂的制备方法,其特征在于:所述胶囊剂的制备工艺为:茯苓部分或全部粉碎成100目以上的细粉;牡丹皮用水蒸汽蒸馏提取丹皮酚;麦冬、五味子和山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子和山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄和泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50-80%的乙醇进行洗脱,回收乙醇,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏和茯苓粉混合制粒,微波干燥,粉碎,再与丹皮酚混合均匀,制粒,装入胶囊即得。8. According to the preparation method of the traditional Chinese medicine oral preparation for nourishing the kidney and nourishing the lung according to claim 1 or 2, it is characterized in that: the preparation process of the capsule is: Poria cocos is partially or completely crushed into fine powder above 100 mesh; Extract paeonol from the cortex by steam distillation; Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis are extracted 1-5 times with ethanol reflux, each time for 0.5-5 hours, filter, combine the filtrate and concentrate to a thick paste, distill the aqueous solution of Moutan cortex and medicinal dregs, the medicinal dregs extracted by ethanol from Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis, and the remaining Poria cocos, Chinese yam, rehmannia glutinosa and Alisma alisma, add 3-10 times the amount of water and decoct 1-5 times, each time for 1-5 hours, the extract Filtrate, combine the filtrates, pass through a macroporous adsorption resin column, elute with 50-80% ethanol, recover the ethanol, concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste and Poria powder to mix and granulate , microwave-dried, pulverized, mixed with paeonol evenly, granulated, and packed into capsules. 9. 按照权利要求1或2所述的滋肾养肺的中药口服制剂的制备方法,其特征在于:所述滴丸的制备工艺为:茯苓部分或全部粉碎成80-100目的细粉;再将其放置在超微粉碎设备中继续粉碎至200-300目的微粉;牡丹皮用水蒸汽蒸馏,蒸馏液用0.5-5倍量的环糊精进行包合,包合物低温干燥,粉碎成细粉即得;麦冬、五味子和山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩成清膏,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子和山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄和泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50-80%的乙醇进行洗脱,回收乙醇,浓缩成清膏,再加入上述麦冬、五味子、山茱萸清膏和茯苓微粉混合制粒,干燥,再与丹皮酚环糊精包合物混合均匀;将所得的药粉或颗粒加入溶解或乳化在已经加热熔融的聚乙二醇4000、聚乙二醇6000、硬脂酸钠或甘油明胶基质中,保持恒定温度78-102℃,用滴管滴入甲基硅油中,收集滴丸即得。9. according to the preparation method of the Chinese medicine oral preparation of nourishing the kidney and nourishing the lung described in claim 1 or 2, it is characterized in that: the preparation process of described dropping pill is: poria cocos part or all is pulverized into 80-100 purpose fine powder; Place it in the ultrafine pulverization equipment and continue pulverizing to 200-300 mesh micropowder; Moutan cortex is steam distilled, the distillate is clathrated with 0.5-5 times the amount of cyclodextrin, the clathrate is dried at low temperature, and pulverized into fine powder That is: Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis are extracted 1-5 times with ethanol reflux, each time for 0.5-5 hours, filtered, combined filtrate and concentrated into a clear paste, distilled aqueous solution of Moutan cortex and medicinal residues, Ophiopogon japonicus, Ophiopogon japonicus, Add 3-10 times the amount of water to decoct the dregs after ethanol extraction of Schisandra chinensis and Cornus officinalis and the remaining Poria cocos, Chinese yam, Rehmannia glutinosa and Alisma 1-5 times, 1-5 hours each time, filter the extract, combine the filtrate, and pass The macroporous adsorption resin column is eluted with 50-80% ethanol, the ethanol is recovered, concentrated into a clear paste, and then the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis clear paste and Poria micropowder are mixed and granulated, dried, and then mixed with paeonol Mix the cyclodextrin inclusion compound evenly; add the obtained drug powder or granules into the dissolved or emulsified polyethylene glycol 4000, polyethylene glycol 6000, sodium stearate or glycerin gelatin matrix that has been heated and melted, and keep a constant temperature of 78 -102°C, use a dropper to drop into methyl silicone oil, and collect drop pills. 10. 按照权利要求1或2所述的滋肾养肺的中药口服制剂的制备方法,其特征在于:所述丸剂的制备工艺为:茯苓部分或全部粉碎成100目以上的细粉;牡丹皮用水蒸汽蒸馏提取丹皮酚,并在收集的馏液中加入1mol/L盐酸使其结晶,滤过,结晶用水洗涤,低温干燥,研成细粉;麦冬、五味子和山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子和山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄和泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50-80%的乙醇进行洗脱,回收乙醇,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏和茯苓粉混合,进行喷雾干燥,粉碎,过60目及60目以上的筛网,加入丹皮酚混合均匀,再加入药粉量0.3-1倍量的炼蜜合药,制成蜜丸即可。10. According to the preparation method of the traditional Chinese medicine oral preparation for nourishing the kidney and nourishing the lung according to claim 1 or 2, it is characterized in that: the preparation process of the pill is: Poria cocos is partially or completely pulverized into a fine powder above 100 mesh; Cortex Moutan Extract paeonol by steam distillation, and add 1mol/L hydrochloric acid to the collected distillate to crystallize, filter, wash the crystals with water, dry at low temperature, and grind into fine powder; Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis are extracted with ethanol 1 -5 times, 0.5-5 hours each time, filter, combine the filtrates and concentrate to a thick paste, distill the aqueous solution of Moutan cortex and herb residues, the ethanol extracts of Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis and the remaining Poria cocos , Chinese yam, Rehmannia glutinosa and Alisma, add 3-10 times the amount of water and decoct 1-5 times, each time for 1-5 hours, filter the extract, combine the filtrate, pass through a macroporous adsorption resin column, and use 50-80% ethanol Perform elution, recover ethanol, concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste and Poria powder, spray dry, crush, pass through a sieve of 60 mesh or above, add paeonol Mix evenly, then add 0.3-1 times the amount of powdered honey and medicine to make honeyed pills. 11. 按照权利要求1或2所述的滋肾养肺的中药口服制剂的制备方法,其特征在于:所述片剂的制备工艺为:茯苓部分或全部粉碎成100目以上的细粉;牡丹皮用水蒸汽蒸馏,蒸馏液用0.5-5倍量的环糊精进行包合,包合物低温干燥,粉碎成细粉即得;麦冬、五味子和山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子和山茱萸乙醇提取后的药渣与剩余的茯苓、山药、熟地黄和泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,通过大孔吸附树脂柱,用50-80%的乙醇进行洗脱,回收乙醇,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏和茯苓粉混合,进行喷雾干燥,加入处方量5-20%淀粉和上述丹皮酚环糊精包合物混匀,用乙醇制粒,再加入干颗粒量0.5-1%硬脂酸镁混匀,压片,用2-8%薄膜包衣剂对素片进行包衣,即得片剂。11. According to the preparation method of the traditional Chinese medicine oral preparation for nourishing the kidney and nourishing the lung according to claim 1 or 2, it is characterized in that: the preparation process of the tablet is: the poria cocos is partially or completely crushed into a fine powder of more than 100 mesh; The skin is distilled with steam, and the distillate is clathrated with 0.5-5 times the amount of cyclodextrin. The clathrate is dried at low temperature and crushed into a fine powder; Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis are extracted 1-5 times with ethanol reflux. After 0.5-5 hours, filter, combine the filtrates and concentrate to a thick paste, distill the aqueous solution of Moutan cortex and medicinal residues, the medicinal residues after ethanol extraction of Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis, and the remaining Poria cocos, Chinese yam, Rehmannia glutinosa and Ze Add 3-10 times the amount of water to decoct 1-5 times, each time for 1-5 hours, filter the extract, combine the filtrate, pass through a macroporous adsorption resin column, elute with 50-80% ethanol, and recover Ethanol, concentrated to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste and Poria cocos powder to mix, spray dry, add 5-20% of the prescription amount of starch and the above-mentioned paeonol-cyclodextrin inclusion compound and mix well, Granulate with ethanol, add 0.5-1% magnesium stearate to the dry granules, mix evenly, press into tablets, and coat the plain tablets with 2-8% film coating agent to obtain tablets. 12. 按照权利要求1或2所述的滋肾养肺的中药口服制剂的制备方法,其特征在于:所述颗粒剂的制备工艺为:牡丹皮用水蒸汽蒸馏提取丹皮酚,并在收集的馏液中加入1mol/L盐酸使其结晶,滤过,结晶用水洗涤,低温干燥,研成细粉;麦冬、五味子和山茱萸用乙醇回流提取1-5次,每次0.5-5小时、滤过、合并滤液并浓缩至稠膏状,将牡丹皮蒸馏后的水溶液及药渣,麦冬、五味子和山茱萸乙醇提取后的药渣与茯苓、山药、熟地黄和泽泻加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,浓缩至稠膏状,再加入上述麦冬、五味子、山茱萸稠膏、丹皮酚和2-5倍量的辅料混匀,制粒,即得颗粒剂;本发明颗粒剂所使用的辅料包括糊精、蔗糖或乳糖。12. According to the preparation method of the traditional Chinese medicine oral preparation for nourishing the kidney and nourishing the lung according to claim 1 or 2, it is characterized in that: the preparation process of the granule is: paeonol is extracted from Moutan cortex with steam distillation, and the collected Add 1mol/L hydrochloric acid to the distillate to crystallize, filter, wash the crystals with water, dry at low temperature, and grind into fine powder; Radix Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis are extracted 1-5 times with ethanol reflux, each time for 0.5-5 hours, filter After filtering and merging the filtrates and concentrating to a thick paste, add 3-10 times the amount of water to the distilled aqueous solution of Moutan cortex and medicinal residues, the medicinal residues after ethanol extraction of Ophiopogon japonicus, Schisandra chinensis and Cornus officinalis, Poria cocos, Chinese yam, rehmannia glutinosa and Alisma Decoct 1-5 times, 1-5 hours each time, filter the extract, combine the filtrate, concentrate to a thick paste, then add the above-mentioned Ophiopogon japonicus, Schisandra, Cornus officinalis thick paste, paeonol and 2-5 times the amount of The auxiliary materials are mixed and granulated to obtain granules; the auxiliary materials used in the granules of the present invention include dextrin, sucrose or lactose. 13. 按照权利要求1或2所述的滋肾养肺的中药口服制剂的制备方法,其特征在于:所述口服液体制剂的制备工艺为:牡丹皮用水蒸汽蒸馏,收集蒸馏液即得;剩下的药物加入3-10倍量的水煎煮1-5次,每次1-5小时,提取液滤过,合并滤液,滤过,滤液浓缩,静置10-50小时,取上清液,滤过,滤液继续浓缩,冷藏10-50小时,滤过滤液加入蔗糖使最终含糖量5-60%,煮沸溶解,滤过,加入0.06%-0.8%苯甲酸钠,加水至全量,搅匀,即得。13. According to the preparation method of the traditional Chinese medicine oral preparation for nourishing the kidney and nourishing the lung according to claim 1 or 2, it is characterized in that: the preparation process of the oral liquid preparation is: the Cortex Moutan is steam distilled, and the distillate is collected; Add 3-10 times the amount of water to the drug and decoct 1-5 times, 1-5 hours each time, filter the extract, combine the filtrate, filter, concentrate the filtrate, let it stand for 10-50 hours, and take the supernatant , filter, continue to concentrate the filtrate, refrigerate for 10-50 hours, add sucrose to the filtrate to make the final sugar content 5-60%, boil to dissolve, filter, add 0.06%-0.8% sodium benzoate, add water to the full amount, stir well , that is.
CNB2005100030544A 2005-04-28 2005-04-28 Traditional Chinese medicine oral preparation for nourishing kidney and lung and preparation method thereof Expired - Lifetime CN100420471C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100030544A CN100420471C (en) 2005-04-28 2005-04-28 Traditional Chinese medicine oral preparation for nourishing kidney and lung and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100030544A CN100420471C (en) 2005-04-28 2005-04-28 Traditional Chinese medicine oral preparation for nourishing kidney and lung and preparation method thereof

Publications (2)

Publication Number Publication Date
CN1695728A CN1695728A (en) 2005-11-16
CN100420471C true CN100420471C (en) 2008-09-24

Family

ID=35348717

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100030544A Expired - Lifetime CN100420471C (en) 2005-04-28 2005-04-28 Traditional Chinese medicine oral preparation for nourishing kidney and lung and preparation method thereof

Country Status (1)

Country Link
CN (1) CN100420471C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102225152A (en) * 2011-06-23 2011-10-26 贵州弘康药业有限公司 Preparation method of Maiwei rehmannia oral preparation

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103860565B (en) * 2012-12-10 2017-05-17 中国人民解放军军事医学科学院毒物药物研究所 Medicinal composition for treating diabetes hepatic fibrosis
CN105343498A (en) * 2014-12-26 2016-02-24 杭州美誉医药有限公司 Traditional Chinese medicine preparation for moistening lungs and preparation method and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1362229A (en) * 2001-01-08 2002-08-07 杨孟君 Nano Maiwei Rehmannine Praeparatae medicine and its preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1362229A (en) * 2001-01-08 2002-08-07 杨孟君 Nano Maiwei Rehmannine Praeparatae medicine and its preparation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中华人民共和国卫生部药品标准WS-B-0938-91. 中华人民共和国卫生部药典委员会,71. 1992
中华人民共和国卫生部药品标准WS-B-0938-91. 中华人民共和国卫生部药典委员会,71. 1992 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102225152A (en) * 2011-06-23 2011-10-26 贵州弘康药业有限公司 Preparation method of Maiwei rehmannia oral preparation
CN102225152B (en) * 2011-06-23 2012-07-25 贵州弘康药业有限公司 Preparation method of Maiwei rehmannia oral preparation

Also Published As

Publication number Publication date
CN1695728A (en) 2005-11-16

Similar Documents

Publication Publication Date Title
JP6091651B2 (en) Pharmaceutical composition for treating headache and method for preparing the same
CN102145129B (en) Method for preparing medicinal composition for treating anemofrigid cold
CN102416139B (en) Chinese medicine composition for treating breast diseases
CN100584373C (en) Preparation method of medicine for treating cerebral apoplexy and its sequelae
KR101088539B1 (en) Chinese Medicine Compositions, Formulations and Methods for Making the Same
JP2016539955A (en) Drug composition, method for producing the same, and use
CN106581335A (en) Medicine composition for treating Alzheimer&#39;s disease and preparing method and application thereof
CN104688688A (en) Aerosol precursor containing effective components of oral drug for treating rhinitis and method for dispersing effective components into nanoscale droplets
CN102793839A (en) Taste-modifying Chinese medicinal preparation and preparation method thereof
CN105362975A (en) Traditional Chinese medicine granule for treating postpartum lochiorrhea and lesser-abdominal pain and preparation method thereof
CN102920964B (en) Traditional Chinese medicine preparation for curing cough
CN100420471C (en) Traditional Chinese medicine oral preparation for nourishing kidney and lung and preparation method thereof
CN105031005A (en) Micro pills capable of tonifying qi and benefiting blood
CN100490785C (en) Freeze-dried &#39;Shengmai&#39; powder for injection and its preparing process
CN1413697A (en) Method for preparing Chinese medicine Liuwei Dihuang preparation
CN101919919B (en) Fukean dispersible tablet and preparation method thereof
CN101693052B (en) Violet light pellet and preparation method thereof
CN1321632C (en) Compound saussurea involucrata capsule and its preparation process
CN115531493B (en) Compound preparation and preparation method thereof
CN100363018C (en) Honeysuckle soft capsule preparation and preparation method thereof
CN104474040A (en) Medicine composition for preventing and treating migraine disease, as well as preparation method and application thereof
CN1325104C (en) Method for preparing Chinese medicine concentrated pill for treating women&#39;s cimacteric metancholia
CN100435842C (en) Chinese-medicinal preparation for treating hypertension and its making method
CN115887547B (en) Use of a traditional Chinese medicine composition in preparing a medicine for treating neurogenic pulmonary edema
CN102363017A (en) Chinese medicinal composition having effects of clearing away heat and toxic materials, promoting blood circulation by removing blood stasis, removing dampness through diuresis and reducing phlegm and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20080924